The name of this superfamily has been modified since the most recent official CATH+ release (v4_2_0). At the point of the last release, this superfamily was named:
"Transferase(Phosphotransferase) domain 1
".
FunFam 79298: Punt receptor serine/threonine kinase
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 134 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Transforming growth factor beta receptor activity, type I GO:0005025
Combining with a complex of transforming growth factor beta and a type II TGF-beta receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of TGF-beta signals.
|
85 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
A0A0B4K7J3 (/ISS)
A1Z7L8 (/ISS)
A1Z7L9 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
(75 more) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
72 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
A0A087RK12 (/ISS)
A0A087VDQ2 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
(62 more) |
Signal transducer activity, downstream of receptor GO:0005057
Conveys a signal from an upstream receptor or intracellular signal transducer, converting the signal into a form where it can ultimately trigger a change in the state or activity of a cell.
|
69 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
F7DAS1 (/ISS)
(59 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
42 |
A0A0B4K7J3 (/IPI)
B3DJG0 (/IPI)
O00238 (/IPI)
O35607 (/IPI)
O73736 (/IPI)
O93243 (/IPI)
P20792 (/IPI)
P27037 (/IPI)
P27038 (/IPI)
P27040 (/IPI)
(32 more) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
24 |
A0A0B4K7J3 (/NAS)
A0A0B4KG59 (/NAS)
A1Z7L8 (/NAS)
A1Z7L9 (/NAS)
M9PE88 (/NAS)
Q23975 (/NAS)
Q24229 (/NAS)
Q24326 (/NAS)
Q24468 (/NAS)
Q7JPM7 (/NAS)
(14 more) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
16 |
A0A0B4KG59 (/IDA)
A1Z7L8 (/IDA)
A1Z7L9 (/IDA)
P27040 (/IDA)
P37023 (/IDA)
P38444 (/IDA)
P38445 (/IDA)
P70539 (/IDA)
Q04771 (/IDA)
Q23975 (/IDA)
(6 more) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
13 |
P36897 (/IPI)
P37023 (/IPI)
P37173 (/IPI)
Q06900 (/IPI)
Q24326 (/IPI)
Q62312 (/IPI)
Q64729 (/IPI)
Q7JQ37 (/IPI)
Q7KTP1 (/IPI)
Q8IPK9 (/IPI)
(3 more) |
Transforming growth factor beta receptor activity, type I GO:0005025
Combining with a complex of transforming growth factor beta and a type II TGF-beta receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of TGF-beta signals.
|
12 |
A0A0B4K7J3 (/NAS)
Q24326 (/NAS)
Q7JPM7 (/NAS)
Q7JPN8 (/NAS)
Q7JQ36 (/NAS)
Q7JQ37 (/NAS)
Q7JQ39 (/NAS)
Q7KTP1 (/NAS)
Q8IPK9 (/NAS)
Q95SI0 (/NAS)
(2 more) |
Transforming growth factor beta receptor activity, type I GO:0005025
Combining with a complex of transforming growth factor beta and a type II TGF-beta receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of TGF-beta signals.
|
11 |
A0A0B4K7J3 (/IDA)
P36897 (/IDA)
P37172 (/IDA)
P80203 (/IDA)
Q06900 (/IDA)
Q7JPM7 (/IDA)
Q7JPN8 (/IDA)
Q7JQ36 (/IDA)
Q7JQ39 (/IDA)
Q90ZK6 (/IDA)
(1 more) |
SMAD binding GO:0046332
Interacting selectively and non-covalently with a SMAD signaling protein.
|
11 |
O00238 (/IDA)
P36894 (/IDA)
P36896 (/IDA)
P36897 (/IDA)
P37023 (/IDA)
P37173 (/IDA)
P70539 (/IDA)
P80203 (/IDA)
Q04771 (/IDA)
Q62312 (/IDA)
(1 more) |
BMP receptor activity GO:0098821
Combining with a member of the bone morphogenetic protein (BMP) family, and transmitting a signal across the plasma membrane to initiate a change in cell activity.
|
10 | P27037 (/ISS) P36894 (/ISS) P38444 (/ISS) P80203 (/ISS) Q13873 (/ISS) Q28043 (/ISS) Q28560 (/ISS) Q5RAN0 (/ISS) Q61288 (/ISS) Q78EA7 (/ISS) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
9 | O00238 (/IDA) P27040 (/IDA) P36894 (/IDA) P36896 (/IDA) P36897 (/IDA) P37023 (/IDA) P70539 (/IDA) Q04771 (/IDA) Q61271 (/IDA) |
Transforming growth factor beta-activated receptor activity GO:0005024
Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
9 | B0V0H4 (/IDA) B3DIP3 (/IDA) F1QXI5 (/IDA) P36897 (/IDA) P37023 (/IDA) P37173 (/IDA) Q288P2 (/IDA) Q288P3 (/IDA) Q64729 (/IDA) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
8 | P27038 (/ISO) P27040 (/ISO) P36895 (/ISO) P36898 (/ISO) P37172 (/ISO) Q61271 (/ISO) Q61288 (/ISO) Q64729 (/ISO) |
Transmembrane receptor protein serine/threonine kinase activity GO:0004675
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
8 | P27037 (/TAS) P36894 (/TAS) P38444 (/TAS) P38445 (/TAS) P80201 (/TAS) P80202 (/TAS) P80203 (/TAS) Q61271 (/TAS) |
Transforming growth factor beta receptor activity, type II GO:0005026
Combining with transforming growth factor beta to initiate a change in cell activity; upon ligand binding, binds to and catalyzes the phosphorylation of a type I TGF-beta receptor.
|
8 | A0A0B4KG59 (/ISS) M9PE88 (/ISS) Q24229 (/ISS) Q24468 (/ISS) Q95T01 (/ISS) Q95V83 (/ISS) Q9NGX8 (/ISS) Q9VZI9 (/ISS) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
7 | O00238 (/IDA) P36894 (/IDA) P36896 (/IDA) P36897 (/IDA) P37023 (/IDA) P70539 (/IDA) Q04771 (/IDA) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
7 | A0A087RK12 (/ISS) A0A087VDQ2 (/ISS) G1NF73 (/ISS) G3X8L8 (/ISS) H0YZF5 (/ISS) R0LPX2 (/ISS) U3K3F2 (/ISS) |
SMAD binding GO:0046332
Interacting selectively and non-covalently with a SMAD signaling protein.
|
7 | P36895 (/ISO) P36898 (/ISO) P37172 (/ISO) Q61271 (/ISO) Q61288 (/ISO) Q62312 (/ISO) Q64729 (/ISO) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
7 | P36897 (/IDA) P37172 (/IDA) P37173 (/IDA) P80204 (/IDA) Q04771 (/IDA) Q06900 (/IDA) Q90999 (/IDA) |
Transforming growth factor beta-activated receptor activity GO:0005024
Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
6 | A0A0B4KG59 (/IGI) Q24229 (/IGI) Q24468 (/IGI) Q62312 (/IGI) Q64729 (/IGI) Q95T01 (/IGI) |
Transforming growth factor beta receptor activity, type I GO:0005025
Combining with a complex of transforming growth factor beta and a type II TGF-beta receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of TGF-beta signals.
|
6 | Q24326 (/IGI) Q7JQ37 (/IGI) Q7KTP1 (/IGI) Q8IPK9 (/IGI) Q95SI0 (/IGI) Q9VMT1 (/IGI) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
6 | P36895 (/ISO) P36898 (/ISO) P37172 (/ISO) Q61271 (/ISO) Q61288 (/ISO) Q64729 (/ISO) |
Activin receptor activity, type I GO:0016361
Combining with activin-bound type II activin receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of activin signals.
|
6 | P36896 (/IDA) P37023 (/IDA) P37172 (/IDA) P70539 (/IDA) P80201 (/IDA) Q8NER5 (/IDA) |
Activin receptor activity, type I GO:0016361
Combining with activin-bound type II activin receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of activin signals.
|
6 | A1Z7L8 (/ISS) A1Z7L9 (/ISS) Q23975 (/ISS) Q28041 (/ISS) Q7YU60 (/ISS) Q8K348 (/ISS) |
Transmembrane receptor protein serine/threonine kinase activity GO:0004675
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
4 | O00238 (/NAS) P36896 (/NAS) P37023 (/NAS) Q04771 (/NAS) |
G-protein coupled receptor kinase activity GO:0004703
Catalysis of the reaction: ATP + G-protein coupled receptor = ADP + G-protein coupled receptor phosphate.
|
4 | A1Z7L8 (/ISS) A1Z7L9 (/ISS) Q23975 (/ISS) Q7YU60 (/ISS) |
Transforming growth factor beta receptor activity, type II GO:0005026
Combining with transforming growth factor beta to initiate a change in cell activity; upon ligand binding, binds to and catalyzes the phosphorylation of a type I TGF-beta receptor.
|
4 | A0A0B4KG59 (/NAS) Q24229 (/NAS) Q24468 (/NAS) Q95T01 (/NAS) |
Activin-activated receptor activity GO:0017002
Combining with activin and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. Activin is one of two gonadal glycoproteins related to transforming growth factor beta.
|
4 | A0A0B4KG59 (/IDA) Q24229 (/IDA) Q24468 (/IDA) Q95T01 (/IDA) |
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
|
4 | P27038 (/IPI) P27040 (/IPI) Q13705 (/IPI) Q8NER5 (/IPI) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
4 | P27038 (/IPI) P27040 (/IPI) P37172 (/IPI) Q61271 (/IPI) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
4 | P37172 (/ISO) Q61288 (/ISO) Q62312 (/ISO) Q64729 (/ISO) |
BMP receptor activity GO:0098821
Combining with a member of the bone morphogenetic protein (BMP) family, and transmitting a signal across the plasma membrane to initiate a change in cell activity.
|
4 | O35607 (/IMP) P27038 (/IMP) P36895 (/IMP) P37023 (/IMP) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
3 | P27037 (/EXP) P36896 (/EXP) Q13705 (/EXP) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
3 | P27038 (/TAS) P36896 (/TAS) Q8NER5 (/TAS) |
Transforming growth factor beta-activated receptor activity GO:0005024
Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
3 | Q61288 (/ISO) Q62312 (/ISO) Q64729 (/ISO) |
Activin receptor activity, type I GO:0016361
Combining with activin-bound type II activin receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of activin signals.
|
3 | Q61271 (/ISO) Q61288 (/ISO) Q8K348 (/ISO) |
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
|
3 | F1LQC5 (/IMP) P27038 (/IMP) P27040 (/IMP) |
BMP binding GO:0036122
Interacting selectively and non-covalently with a member of the bone morphogenetic protein (BMP) family.
|
3 | P50488 (/IPI) Q13873 (/IPI) Q8ITX8 (/IPI) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
3 | F1NCI7 (/IMP) Q90669 (/IMP) Q90670 (/IMP) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
3 | P37172 (/ISO) Q61288 (/ISO) Q8K348 (/ISO) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
3 | P38444 (/TAS) P38445 (/TAS) Q90ZK6 (/TAS) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
3 | Q06900 (/ISA) Q90999 (/ISA) Q90ZK6 (/ISA) |
Glycoprotein binding GO:0001948
Interacting selectively and non-covalently with a glycoprotein, a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans.
|
2 | O00238 (/IPI) P36894 (/IPI) |
Glycoprotein binding GO:0001948
Interacting selectively and non-covalently with a glycoprotein, a protein that contains covalently bound glycose (monosaccharide) residues. These also include proteoglycans.
|
2 | P36895 (/ISO) P36898 (/ISO) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
2 | P36897 (/IDA) Q04771 (/IDA) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Protein kinase activity GO:0004672
Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
|
2 | P37172 (/ISO) Q64729 (/ISO) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | P80204 (/IMP) Q13705 (/IMP) |
Protein serine/threonine kinase activity GO:0004674
Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Transmembrane receptor protein serine/threonine kinase activity GO:0004675
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | F1LQC5 (/IMP) O00238 (/IMP) |
Transmembrane receptor protein serine/threonine kinase activity GO:0004675
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | P36898 (/ISO) Q62312 (/ISO) |
Transmembrane receptor protein serine/threonine kinase activity GO:0004675
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | P50488 (/ISS) Q8ITX8 (/ISS) |
Signal transducer, downstream of receptor, with serine/threonine kinase activity GO:0004702
Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | P80203 (/IDA) Q64729 (/IDA) |
Signal transducer, downstream of receptor, with serine/threonine kinase activity GO:0004702
Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | P80201 (/IMP) P80202 (/IMP) |
Transforming growth factor beta-activated receptor activity GO:0005024
Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | P36897 (/IC) P37173 (/IC) |
Transforming growth factor beta-activated receptor activity GO:0005024
Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | P36897 (/IMP) P37173 (/IMP) |
Transforming growth factor beta-activated receptor activity GO:0005024
Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
2 | Q06900 (/ISA) Q90999 (/ISA) |
Transforming growth factor beta receptor activity, type I GO:0005025
Combining with a complex of transforming growth factor beta and a type II TGF-beta receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of TGF-beta signals.
|
2 | P36898 (/IMP) P80204 (/IMP) |
Transforming growth factor beta receptor activity, type I GO:0005025
Combining with a complex of transforming growth factor beta and a type II TGF-beta receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of TGF-beta signals.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Signal transducer activity, downstream of receptor GO:0005057
Conveys a signal from an upstream receptor or intracellular signal transducer, converting the signal into a form where it can ultimately trigger a change in the state or activity of a cell.
|
2 | Q06900 (/IMP) Q90ZK6 (/IMP) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
2 | O73736 (/ISS) Q9DGI6 (/ISS) |
Activin receptor activity, type I GO:0016361
Combining with activin-bound type II activin receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of activin signals.
|
2 | P80201 (/IMP) P80202 (/IMP) |
Activin receptor activity, type I GO:0016361
Combining with activin-bound type II activin receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of activin signals.
|
2 | P36896 (/TAS) P80202 (/TAS) |
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
|
2 | F1LQC5 (/IDA) P37172 (/IDA) |
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
|
2 | P27040 (/ISO) Q8K348 (/ISO) |
Growth factor binding GO:0019838
Interacting selectively and non-covalently with any growth factor, proteins or polypeptides that stimulate a cell or organism to grow or proliferate.
|
2 | P70539 (/ISS) Q8K348 (/ISS) |
Inhibin binding GO:0034711
Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers.
|
2 | P38444 (/IDA) P38445 (/IDA) |
Inhibin binding GO:0034711
Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers.
|
2 | P27038 (/IPI) P36896 (/IPI) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
2 | P37173 (/IDA) Q90999 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | P36894 (/IDA) Q04771 (/IDA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | P36895 (/ISO) P37172 (/ISO) |
SMAD binding GO:0046332
Interacting selectively and non-covalently with a SMAD signaling protein.
|
2 | P80201 (/IMP) P80202 (/IMP) |
SMAD binding GO:0046332
Interacting selectively and non-covalently with a SMAD signaling protein.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Metal ion binding GO:0046872
Interacting selectively and non-covalently with any metal ion.
|
2 | P70539 (/IC) Q8NER5 (/IC) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
2 | Q06900 (/IMP) Q90999 (/IMP) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
2 | P80203 (/TAS) Q90ZK6 (/TAS) |
RNA polymerase II transcription factor activity, sequence-specific DNA binding GO:0000981
Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription by RNA polymerase II. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.
|
1 | P36895 (/IDA) |
Transmembrane receptor protein serine/threonine kinase activity GO:0004675
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
1 | P37173 (/IDA) |
Transmembrane receptor protein serine/threonine kinase activity GO:0004675
Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
1 | Q90999 (/ISA) |
Protein serine/threonine/tyrosine kinase activity GO:0004712
Catalysis of the reactions: ATP + a protein serine = ADP + protein serine phosphate; ATP + a protein threonine = ADP + protein threonine phosphate; and ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
|
1 | P27040 (/IDA) |
Transforming growth factor beta-activated receptor activity GO:0005024
Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
1 | P20792 (/ISS) |
Transforming growth factor beta-activated receptor activity GO:0005024
Combining with a transforming growth factor beta (TGFbeta) and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.
|
1 | P36898 (/TAS) |
Transforming growth factor beta receptor activity, type I GO:0005025
Combining with a complex of transforming growth factor beta and a type II TGF-beta receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of TGF-beta signals.
|
1 | Q64729 (/ISO) |
Transforming growth factor beta receptor activity, type II GO:0005026
Combining with transforming growth factor beta to initiate a change in cell activity; upon ligand binding, binds to and catalyzes the phosphorylation of a type I TGF-beta receptor.
|
1 | P38438 (/IMP) |
Transforming growth factor beta receptor activity, type II GO:0005026
Combining with transforming growth factor beta to initiate a change in cell activity; upon ligand binding, binds to and catalyzes the phosphorylation of a type I TGF-beta receptor.
|
1 | P38438 (/TAS) |
Receptor binding GO:0005102
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | Q64729 (/IPI) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
1 | P36897 (/IDA) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
1 | P36897 (/IPI) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
1 | Q06900 (/ISA) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
1 | Q64729 (/ISO) |
ATP binding GO:0005524
Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
1 | P80204 (/IMP) |
Glycosaminoglycan binding GO:0005539
Interacting selectively and non-covalently with any glycan (polysaccharide) containing a substantial proportion of aminomonosaccharide residues.
|
1 | P37173 (/IDA) |
Glycosaminoglycan binding GO:0005539
Interacting selectively and non-covalently with any glycan (polysaccharide) containing a substantial proportion of aminomonosaccharide residues.
|
1 | Q90999 (/ISA) |
Glycosaminoglycan binding GO:0005539
Interacting selectively and non-covalently with any glycan (polysaccharide) containing a substantial proportion of aminomonosaccharide residues.
|
1 | Q62312 (/ISO) |
Coreceptor activity GO:0015026
Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity.
|
1 | P27037 (/IDA) |
Coreceptor activity GO:0015026
Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity.
|
1 | P27038 (/ISO) |
Activin receptor activity, type I GO:0016361
Combining with activin-bound type II activin receptor to initiate a change in cell activity; upon binding, acts as a downstream transducer of activin signals.
|
1 | Q90ZK6 (/ISA) |
Activin receptor activity, type II GO:0016362
Combining with activin to initiate a change in cell activity; upon ligand binding, binds to and catalyses the phosphorylation of a type I activin receptor.
|
1 | P38444 (/IDA) |
Activin receptor activity, type II GO:0016362
Combining with activin to initiate a change in cell activity; upon ligand binding, binds to and catalyses the phosphorylation of a type I activin receptor.
|
1 | Q13873 (/TAS) |
Peptide hormone binding GO:0017046
Interacting selectively and non-covalently with any peptide with hormonal activity in animals.
|
1 | Q04771 (/NAS) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
1 | P37023 (/IPI) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
1 | Q61288 (/ISO) |
PDZ domain binding GO:0030165
Interacting selectively and non-covalently with a PDZ domain of a protein, a domain found in diverse signaling proteins.
|
1 | P27038 (/IPI) |
Mitogen-activated protein kinase kinase kinase binding GO:0031435
Interacting selectively and non-covalently with a mitogen-activated protein kinase kinase kinase, any protein that can phosphorylate a MAP kinase kinase.
|
1 | P38438 (/IPI) |
Ubiquitin protein ligase binding GO:0031625
Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
|
1 | P80204 (/IPI) |
Ubiquitin protein ligase binding GO:0031625
Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
|
1 | P36896 (/NAS) |
Protein complex binding GO:0032403
Interacting selectively and non-covalently with any protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
1 | P80204 (/IPI) |
Inhibin binding GO:0034711
Interacting selectively and non-covalently with an inhibin monomer, any of the polypeptides that combine to form activin and inhibin dimers.
|
1 | Q61271 (/ISO) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
1 | P37173 (/IPI) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
1 | Q90999 (/ISA) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
1 | Q62312 (/ISO) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
1 | P37173 (/IDA) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
1 | Q90999 (/ISM) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
1 | Q62312 (/ISO) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
1 | Q90999 (/ISS) |
BMP binding GO:0036122
Interacting selectively and non-covalently with a member of the bone morphogenetic protein (BMP) family.
|
1 | O35607 (/ISO) |
Nodal binding GO:0038100
Interacting selectively and non-covalently with a nodal protein, a member of the transforming growth factor-beta superfamily.
|
1 | Q8NER5 (/IMP) |
Nodal binding GO:0038100
Interacting selectively and non-covalently with a nodal protein, a member of the transforming growth factor-beta superfamily.
|
1 | Q8K348 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | Q90ZK6 (/ISA) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | P38438 (/TAS) |
Protein self-association GO:0043621
Interacting selectively and non-covalently with a domain within the same polypeptide.
|
1 | P27038 (/IPI) |
SMAD binding GO:0046332
Interacting selectively and non-covalently with a SMAD signaling protein.
|
1 | P36897 (/IPI) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
1 | P80204 (/IMP) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
1 | P38438 (/TAS) |
Activin binding GO:0048185
Interacting selectively and non-covalently with activin, a dimer of inhibin-beta subunits.
|
1 | Q90ZK6 (/ISA) |
Transforming growth factor beta binding GO:0050431
Interacting selectively and non-covalently with TGF-beta, transforming growth factor beta, a multifunctional peptide that controls proliferation, differentiation and other functions in many cell types.
|
1 | Q90999 (/ISM) |
I-SMAD binding GO:0070411
Interacting selectively and non-covalently with an inhibitory SMAD signaling protein.
|
1 | P36897 (/IPI) |
I-SMAD binding GO:0070411
Interacting selectively and non-covalently with an inhibitory SMAD signaling protein.
|
1 | Q06900 (/ISA) |
I-SMAD binding GO:0070411
Interacting selectively and non-covalently with an inhibitory SMAD signaling protein.
|
1 | Q64729 (/ISO) |
BMP receptor binding GO:0070700
Interacting selectively and non-covalently with a BMP receptor.
|
1 | P70539 (/IDA) |
BMP receptor activity GO:0098821
Combining with a member of the bone morphogenetic protein (BMP) family, and transmitting a signal across the plasma membrane to initiate a change in cell activity.
|
1 | Q61288 (/ISO) |
There are 834 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Proteoglycan biosynthetic process GO:0030166
The chemical reactions and pathways resulting in the formation of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
|
147 |
A0A087RCG9 (/ISS)
A0A087V8A6 (/ISS)
A0A087VNH5 (/ISS)
A0A091D6I9 (/ISS)
A0A091EPQ5 (/ISS)
A0A091F961 (/ISS)
A0A091G6G8 (/ISS)
A0A091GMN4 (/ISS)
A0A091GR63 (/ISS)
A0A091I2S0 (/ISS)
(137 more) |
Endochondral bone morphogenesis GO:0060350
The process in which bones are generated and organized as a result of the conversion of initial cartilaginous anlage into bone.
|
147 |
A0A087RCG9 (/ISS)
A0A087V8A6 (/ISS)
A0A087VNH5 (/ISS)
A0A091D6I9 (/ISS)
A0A091EPQ5 (/ISS)
A0A091F961 (/ISS)
A0A091G6G8 (/ISS)
A0A091GMN4 (/ISS)
A0A091GR63 (/ISS)
A0A091I2S0 (/ISS)
(137 more) |
Positive regulation of cartilage development GO:0061036
Any process that increases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
147 |
A0A087RCG9 (/ISS)
A0A087V8A6 (/ISS)
A0A087VNH5 (/ISS)
A0A091D6I9 (/ISS)
A0A091EPQ5 (/ISS)
A0A091F961 (/ISS)
A0A091G6G8 (/ISS)
A0A091GMN4 (/ISS)
A0A091GR63 (/ISS)
A0A091I2S0 (/ISS)
(137 more) |
Chondrocyte development GO:0002063
The process whose specific outcome is the progression of a chondrocyte over time, from its commitment to its mature state. Chondrocyte development does not include the steps involved in committing a chondroblast to a chondrocyte fate.
|
81 |
A0A087VNH5 (/ISS)
A0A091D6I9 (/ISS)
A0A091F961 (/ISS)
A0A091G6G8 (/ISS)
A0A091GR63 (/ISS)
A0A091ID58 (/ISS)
A0A091JLL3 (/ISS)
A0A091MGM6 (/ISS)
A0A091MJA6 (/ISS)
A0A091PAA2 (/ISS)
(71 more) |
Negative regulation of chondrocyte proliferation GO:1902731
Any process that stops, prevents, or reduces the frequency, rate or extent of the multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage.
|
81 |
A0A087VNH5 (/ISS)
A0A091D6I9 (/ISS)
A0A091F961 (/ISS)
A0A091G6G8 (/ISS)
A0A091GR63 (/ISS)
A0A091ID58 (/ISS)
A0A091JLL3 (/ISS)
A0A091MGM6 (/ISS)
A0A091MJA6 (/ISS)
A0A091PAA2 (/ISS)
(71 more) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
78 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
A0A087RK12 (/ISS)
A0A087VDQ2 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
(68 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
77 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
A0A0B4K7J3 (/ISS)
A1Z7L8 (/ISS)
A1Z7L9 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
(67 more) |
Mesenchymal cell differentiation GO:0048762
The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
|
76 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
A0A087RK12 (/ISS)
A0A087VDQ2 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
(66 more) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
76 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
A0A087RK12 (/ISS)
A0A087VDQ2 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
(66 more) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
69 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
F7DAS1 (/ISS)
(59 more) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
69 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
F7DAS1 (/ISS)
(59 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
69 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
F7DAS1 (/ISS)
(59 more) |
Regulation of epithelial to mesenchymal transition GO:0010717
Any process that modulates the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
69 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
F7DAS1 (/ISS)
(59 more) |
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
69 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
F7DAS1 (/ISS)
(59 more) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
69 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
F7DAS1 (/ISS)
(59 more) |
Endothelial cell activation GO:0042118
The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
69 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
F7DAS1 (/ISS)
(59 more) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
69 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
F7BNR8 (/ISS)
F7DAS1 (/ISS)
(59 more) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
27 |
A0A0B4K7J3 (/IGI)
A0A0R4I9Y4 (/IGI)
A0A0R4IZG7 (/IGI)
B3DJ37 (/IGI)
B3DJG0 (/IGI)
C0L3D6 (/IGI)
F1RC58 (/IGI)
O73736 (/IGI)
O93243 (/IGI)
P36895 (/IGI)
(17 more) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
24 |
A0A0B4K7J3 (/NAS)
A0A0B4KG59 (/NAS)
A1Z7L8 (/NAS)
A1Z7L9 (/NAS)
M9PE88 (/NAS)
Q23975 (/NAS)
Q24229 (/NAS)
Q24326 (/NAS)
Q24468 (/NAS)
Q7JPM7 (/NAS)
(14 more) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
18 |
A0A0B4K7J3 (/IMP)
A0A0B4KG59 (/IMP)
O73736 (/IMP)
Q24229 (/IMP)
Q24326 (/IMP)
Q24468 (/IMP)
Q7JPM7 (/IMP)
Q7JPN8 (/IMP)
Q7JQ36 (/IMP)
Q7JQ37 (/IMP)
(8 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
18 |
A0A0B4K7J3 (/TAS)
O00238 (/TAS)
P27037 (/TAS)
P36894 (/TAS)
P37023 (/TAS)
Q13705 (/TAS)
Q13873 (/TAS)
Q24326 (/TAS)
Q7JPM7 (/TAS)
Q7JPN8 (/TAS)
(8 more) |
Germ-line stem cell division GO:0042078
The self-renewing division of a germline stem cell to produce a daughter stem cell and a daughter germ cell, which will divide to form the gametes.
|
18 |
A0A0B4K7J3 (/IMP)
A0A0B4KG59 (/IMP)
A0A0R4I9Y4 (/IMP)
C0L3D6 (/IMP)
Q24229 (/IMP)
Q24326 (/IMP)
Q24468 (/IMP)
Q7JPM7 (/IMP)
Q7JPN8 (/IMP)
Q7JQ36 (/IMP)
(8 more) |
Compound eye morphogenesis GO:0001745
The morphogenetic process in which the anatomical structures of the compound eye are generated and organized. The adult compound eye is a precise assembly of 700-800 ommatidia. Each ommatidium is composed of 20 cells, identified by cell type and position. An example of compound eye morphogenesis is found in Drosophila melanogaster.
|
16 |
A0A0B4K7J3 (/NAS)
A0A0B4KG59 (/NAS)
Q24229 (/NAS)
Q24326 (/NAS)
Q24468 (/NAS)
Q7JPM7 (/NAS)
Q7JPN8 (/NAS)
Q7JQ36 (/NAS)
Q7JQ37 (/NAS)
Q7JQ39 (/NAS)
(6 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
A0A0B4K7J3 (/NAS)
A0A0B4KG59 (/NAS)
Q24229 (/NAS)
Q24326 (/NAS)
Q24468 (/NAS)
Q7JPM7 (/NAS)
Q7JPN8 (/NAS)
Q7JQ36 (/NAS)
Q7JQ37 (/NAS)
Q7JQ39 (/NAS)
(6 more) |
Imaginal disc-derived wing morphogenesis GO:0007476
The process in which the anatomical structures of the imaginal disc-derived wing are generated and organized. The wing is an appendage modified for flying.
|
16 |
A0A0B4K7J3 (/IMP)
A1Z7L8 (/IMP)
A1Z7L9 (/IMP)
Q23975 (/IMP)
Q24326 (/IMP)
Q7JPM7 (/IMP)
Q7JPN8 (/IMP)
Q7JQ36 (/IMP)
Q7JQ37 (/IMP)
Q7JQ39 (/IMP)
(6 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
16 |
A0A0R4I9Y4 (/IMP)
B0V0H4 (/IMP)
B3DIP3 (/IMP)
C0L3D6 (/IMP)
F1QXI5 (/IMP)
O35607 (/IMP)
P27037 (/IMP)
P27038 (/IMP)
P36895 (/IMP)
P36898 (/IMP)
(6 more) |
Germ-line stem cell population maintenance GO:0030718
Any process by which an organism or tissue maintains a population of germ-line stem cells.
|
16 |
A0A0B4K7J3 (/IMP)
A0A0B4KG59 (/IMP)
Q24229 (/IMP)
Q24326 (/IMP)
Q24468 (/IMP)
Q7JPM7 (/IMP)
Q7JPN8 (/IMP)
Q7JQ36 (/IMP)
Q7JQ37 (/IMP)
Q7JQ39 (/IMP)
(6 more) |
Positive regulation of synaptic growth at neuromuscular junction GO:0045887
Any process that activates or increases the frequency, rate or extent of synaptic growth at neuromuscular junction.
|
16 |
A0A0B4K7J3 (/IMP)
M9PE88 (/IMP)
Q24326 (/IMP)
Q7JPM7 (/IMP)
Q7JPN8 (/IMP)
Q7JQ36 (/IMP)
Q7JQ37 (/IMP)
Q7JQ39 (/IMP)
Q7KTP1 (/IMP)
Q8IPK9 (/IMP)
(6 more) |
Cartilage development GO:0051216
The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
14 |
A0A0R4ICT5 (/IMP)
A9CAY0 (/IMP)
A9CAY1 (/IMP)
F1Q6M3 (/IMP)
F1QG01 (/IMP)
F1QLL7 (/IMP)
F1R4D0 (/IMP)
O73736 (/IMP)
P36895 (/IMP)
Q4V965 (/IMP)
(4 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
13 |
A0A0R4I9Y4 (/IGI)
A0A0R4IZG7 (/IGI)
B3DJG0 (/IGI)
C0L3D6 (/IGI)
F1RC58 (/IGI)
O73736 (/IGI)
O93243 (/IGI)
P36895 (/IGI)
P36898 (/IGI)
Q1RLX1 (/IGI)
(3 more) |
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
13 |
A0A0B4KG59 (/IDA)
A1Z7L8 (/IDA)
A1Z7L9 (/IDA)
P36896 (/IDA)
Q04771 (/IDA)
Q06900 (/IDA)
Q23975 (/IDA)
Q24229 (/IDA)
Q24468 (/IDA)
Q61271 (/IDA)
(3 more) |
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
13 |
O00238 (/IMP)
O35607 (/IMP)
P20792 (/IMP)
P27037 (/IMP)
P36894 (/IMP)
P36895 (/IMP)
P37172 (/IMP)
P50488 (/IMP)
P80202 (/IMP)
Q04771 (/IMP)
(3 more) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
12 |
A0A0R4ICT5 (/IMP)
A9CAY0 (/IMP)
A9CAY1 (/IMP)
F1Q6M3 (/IMP)
F1QG01 (/IMP)
F1QLL7 (/IMP)
F1R4D0 (/IMP)
O00238 (/IMP)
P27040 (/IMP)
Q4V965 (/IMP)
(2 more) |
Chorion-containing eggshell formation GO:0007304
The construction of a chorion-containing eggshell. An example of this is found in Drosophila melanogaster.
|
12 |
A0A0B4K7J3 (/IGI)
Q24326 (/IGI)
Q7JPM7 (/IGI)
Q7JPN8 (/IGI)
Q7JQ36 (/IGI)
Q7JQ37 (/IGI)
Q7JQ39 (/IGI)
Q7KTP1 (/IGI)
Q8IPK9 (/IGI)
Q95SI0 (/IGI)
(2 more) |
Anterior/posterior pattern specification, imaginal disc GO:0007448
The establishment, maintenance and elaboration of the anterior/posterior axis of the imaginal disc. Imaginal discs are epithelial infoldings in the larvae of holometabolous insects that rapidly develop into adult appendages during metamorphosis from larval to adult form.
|
12 |
A0A0B4K7J3 (/IMP)
Q24326 (/IMP)
Q7JPM7 (/IMP)
Q7JPN8 (/IMP)
Q7JQ36 (/IMP)
Q7JQ37 (/IMP)
Q7JQ39 (/IMP)
Q7KTP1 (/IMP)
Q8IPK9 (/IMP)
Q95SI0 (/IMP)
(2 more) |
Decapentaplegic signaling pathway GO:0008101
A series of molecular signals initiated by the binding of decapentaplegic (dpp) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
12 |
A0A0B4K7J3 (/IGI)
Q24326 (/IGI)
Q7JPM7 (/IGI)
Q7JPN8 (/IGI)
Q7JQ36 (/IGI)
Q7JQ37 (/IGI)
Q7JQ39 (/IGI)
Q7KTP1 (/IGI)
Q8IPK9 (/IGI)
Q95SI0 (/IGI)
(2 more) |
Decapentaplegic signaling pathway GO:0008101
A series of molecular signals initiated by the binding of decapentaplegic (dpp) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
12 |
A0A0B4K7J3 (/IMP)
Q24326 (/IMP)
Q7JPM7 (/IMP)
Q7JPN8 (/IMP)
Q7JQ36 (/IMP)
Q7JQ37 (/IMP)
Q7JQ39 (/IMP)
Q7KTP1 (/IMP)
Q8IPK9 (/IMP)
Q95SI0 (/IMP)
(2 more) |
Ovarian follicle cell development GO:0030707
The process that occurs during oogenesis involving the ovarian follicle cells, somatic cells which surround the germ cells of an ovary. An example of this is found in Drosophila melanogaster.
|
12 |
A0A0B4K7J3 (/TAS)
Q24326 (/TAS)
Q7JPM7 (/TAS)
Q7JPN8 (/TAS)
Q7JQ36 (/TAS)
Q7JQ37 (/TAS)
Q7JQ39 (/TAS)
Q7KTP1 (/TAS)
Q8IPK9 (/TAS)
Q95SI0 (/TAS)
(2 more) |
Dendrite morphogenesis GO:0048813
The process in which the anatomical structures of a dendrite are generated and organized. A dendrite is a freely branching protoplasmic process of a nerve cell.
|
12 |
A0A0B4KG59 (/NAS)
A1Z7L8 (/NAS)
A1Z7L9 (/NAS)
M9PE88 (/NAS)
Q23975 (/NAS)
Q24229 (/NAS)
Q24468 (/NAS)
Q7YU60 (/NAS)
Q95T01 (/NAS)
Q95V83 (/NAS)
(2 more) |
Neural crest cell migration GO:0001755
The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo.
|
11 |
A0A0R4ICT5 (/IMP)
A9CAY0 (/IMP)
A9CAY1 (/IMP)
F1Q6M3 (/IMP)
F1QG01 (/IMP)
F1QLL7 (/IMP)
F1R4D0 (/IMP)
P37172 (/IMP)
Q4V965 (/IMP)
Q56E96 (/IMP)
(1 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
11 |
A0A0B4KG59 (/IGI)
Q24229 (/IGI)
Q24326 (/IGI)
Q24468 (/IGI)
Q64729 (/IGI)
Q7JQ37 (/IGI)
Q7KTP1 (/IGI)
Q8IPK9 (/IGI)
Q95SI0 (/IGI)
Q95T01 (/IGI)
(1 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
11 |
A0A0B4KG59 (/IMP)
P36897 (/IMP)
P37173 (/IMP)
P38438 (/IMP)
P80201 (/IMP)
P80204 (/IMP)
Q24229 (/IMP)
Q24468 (/IMP)
Q62312 (/IMP)
Q64729 (/IMP)
(1 more) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
10 | A1Z7L8 (/ISS) A1Z7L9 (/ISS) M9PE88 (/ISS) O73736 (/ISS) Q23975 (/ISS) Q7YU60 (/ISS) Q95V83 (/ISS) Q9DGI6 (/ISS) Q9NGX8 (/ISS) Q9VZI9 (/ISS) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
10 | P36897 (/IDA) P37023 (/IDA) P37172 (/IDA) P37173 (/IDA) P80203 (/IDA) Q04771 (/IDA) Q06900 (/IDA) Q61288 (/IDA) Q64729 (/IDA) Q90ZK6 (/IDA) |
Neuromuscular synaptic transmission GO:0007274
The process of communication from a neuron to a muscle, across a synapse.
|
10 | M9PE88 (/IMP) Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q95V83 (/IMP) Q9NGX8 (/IMP) Q9VMT1 (/IMP) Q9VZI9 (/IMP) |
Dorsal closure GO:0007391
The process during Drosophila embryogenesis whereby the ectodermal cells of the lateral epithelium stretch in a coordinated fashion to internalize the amnioserosa cells and close the embryo dorsally.
|
10 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24326 (/IMP) Q24468 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q95T01 (/IMP) Q9VMT1 (/IMP) |
Dorsal closure GO:0007391
The process during Drosophila embryogenesis whereby the ectodermal cells of the lateral epithelium stretch in a coordinated fashion to internalize the amnioserosa cells and close the embryo dorsally.
|
10 | A0A0B4KG59 (/TAS) Q24229 (/TAS) Q24326 (/TAS) Q24468 (/TAS) Q7JQ37 (/TAS) Q7KTP1 (/TAS) Q8IPK9 (/TAS) Q95SI0 (/TAS) Q95T01 (/TAS) Q9VMT1 (/TAS) |
Open tracheal system development GO:0007424
The process whose specific outcome is the progression of an open tracheal system over time, from its formation to the mature structure. An open tracheal system is a respiratory system, a branched network of epithelial tubes that supplies oxygen to target tissues via spiracles. An example of this is found in Drosophila melanogaster.
|
10 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24326 (/IMP) Q24468 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q95T01 (/IMP) Q9VMT1 (/IMP) |
Open tracheal system development GO:0007424
The process whose specific outcome is the progression of an open tracheal system over time, from its formation to the mature structure. An open tracheal system is a respiratory system, a branched network of epithelial tubes that supplies oxygen to target tissues via spiracles. An example of this is found in Drosophila melanogaster.
|
10 | A0A0B4KG59 (/TAS) Q24229 (/TAS) Q24326 (/TAS) Q24468 (/TAS) Q7JQ37 (/TAS) Q7KTP1 (/TAS) Q8IPK9 (/TAS) Q95SI0 (/TAS) Q95T01 (/TAS) Q9VMT1 (/TAS) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
10 | A0A0B4KG59 (/IDA) Q24229 (/IDA) Q24326 (/IDA) Q24468 (/IDA) Q7JQ37 (/IDA) Q7KTP1 (/IDA) Q8IPK9 (/IDA) Q95SI0 (/IDA) Q95T01 (/IDA) Q9VMT1 (/IDA) |
Hindbrain development GO:0030902
The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium).
|
10 | A0A0R4ICT5 (/IMP) A9CAY0 (/IMP) A9CAY1 (/IMP) F1Q6M3 (/IMP) F1QG01 (/IMP) F1QLL7 (/IMP) F1R4D0 (/IMP) Q4V965 (/IMP) Q56E96 (/IMP) Q9YGU4 (/IMP) |
Negative regulation of salivary gland boundary specification GO:0045705
Any process that stops, prevents, or reduces the frequency, rate or extent of salivary gland determination.
|
10 | A0A0B4KG59 (/TAS) Q24229 (/TAS) Q24326 (/TAS) Q24468 (/TAS) Q7JQ37 (/TAS) Q7KTP1 (/TAS) Q8IPK9 (/TAS) Q95SI0 (/TAS) Q95T01 (/TAS) Q9VMT1 (/TAS) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
9 | O00238 (/IDA) P36894 (/IDA) P36896 (/IDA) P36897 (/IDA) P37023 (/IDA) P37173 (/IDA) P70539 (/IDA) P80203 (/IDA) Q04771 (/IDA) |
Determination of left/right symmetry GO:0007368
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
|
9 | B0V0H4 (/IMP) B3DIP3 (/IMP) F1QXI5 (/IMP) O73736 (/IMP) P27040 (/IMP) P37172 (/IMP) Q288P2 (/IMP) Q288P3 (/IMP) Q9DGI6 (/IMP) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
9 | A1Z7L8 (/IMP) A1Z7L9 (/IMP) P27037 (/IMP) P37023 (/IMP) P37172 (/IMP) P80202 (/IMP) Q13873 (/IMP) Q23975 (/IMP) Q7YU60 (/IMP) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
8 | A0A087RK12 (/ISS) A0A087VDQ2 (/ISS) G1NF73 (/ISS) G3X8L8 (/ISS) H0YZF5 (/ISS) O00238 (/ISS) R0LPX2 (/ISS) U3K3F2 (/ISS) |
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
|
8 | B0V0H4 (/IMP) B3DIP3 (/IMP) F1QXI5 (/IMP) O73736 (/IMP) Q288P2 (/IMP) Q288P3 (/IMP) Q62312 (/IMP) Q9DGI6 (/IMP) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
8 | A1Z7L8 (/ISS) A1Z7L9 (/ISS) M9PE88 (/ISS) Q23975 (/ISS) Q7YU60 (/ISS) Q95V83 (/ISS) Q9NGX8 (/ISS) Q9VZI9 (/ISS) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
8 | A0A0B4KG59 (/IMP) A1Z7L8 (/IMP) A1Z7L9 (/IMP) Q23975 (/IMP) Q24229 (/IMP) Q24468 (/IMP) Q7YU60 (/IMP) Q95T01 (/IMP) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
8 | A0A087RK12 (/ISS) A0A087VDQ2 (/ISS) G1NF73 (/ISS) G3X8L8 (/ISS) H0YZF5 (/ISS) P36897 (/ISS) R0LPX2 (/ISS) U3K3F2 (/ISS) |
Regulation of glucose metabolic process GO:0010906
Any process that modulates the rate, frequency or extent of glucose metabolism. Glucose metabolic processes are the chemical reactions and pathways involving glucose, the aldohexose gluco-hexose.
|
8 | A0A0B4KG59 (/IMP) A1Z7L8 (/IMP) A1Z7L9 (/IMP) Q23975 (/IMP) Q24229 (/IMP) Q24468 (/IMP) Q7YU60 (/IMP) Q95T01 (/IMP) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
8 | O00238 (/IDA) P27037 (/IDA) P36894 (/IDA) P36895 (/IDA) P36898 (/IDA) Q04771 (/IDA) Q13705 (/IDA) Q13873 (/IDA) |
Negative regulation of BMP signaling pathway GO:0030514
Any process that stops, prevents, or reduces the frequency, rate or extent of the BMP signaling pathway.
|
8 | A0A0B4K7J3 (/IMP) P50488 (/IMP) Q7JPM7 (/IMP) Q7JPN8 (/IMP) Q7JQ36 (/IMP) Q7JQ39 (/IMP) Q8ITX8 (/IMP) Q95U21 (/IMP) |
Neuron development GO:0048666
The process whose specific outcome is the progression of a neuron over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.
|
8 | A0A0B4KG59 (/IMP) A1Z7L8 (/IMP) A1Z7L9 (/IMP) Q23975 (/IMP) Q24229 (/IMP) Q24468 (/IMP) Q7YU60 (/IMP) Q95T01 (/IMP) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
7 | A0A087RK12 (/ISS) A0A087VDQ2 (/ISS) G1NF73 (/ISS) G3X8L8 (/ISS) H0YZF5 (/ISS) R0LPX2 (/ISS) U3K3F2 (/ISS) |
Heart jogging GO:0003146
The morphogenetic process in which the heart cone is displaced to the left with respect to the vector of the anterior-posterior axis.
|
7 | B0V0H4 (/IMP) B3DIP3 (/IMP) F1QXI5 (/IMP) O73736 (/IMP) Q288P2 (/IMP) Q288P3 (/IMP) Q9DGI6 (/IMP) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
7 | P36895 (/ISO) P36898 (/ISO) P37172 (/ISO) Q61271 (/ISO) Q61288 (/ISO) Q62312 (/ISO) Q64729 (/ISO) |
Determination of left/right symmetry GO:0007368
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
|
7 | B0V0H4 (/IGI) B3DIP3 (/IGI) F1QXI5 (/IGI) P27038 (/IGI) P27040 (/IGI) Q288P2 (/IGI) Q288P3 (/IGI) |
Germ cell migration GO:0008354
The orderly movement of a cell specialized to produce haploid gametes through the embryo from its site of production to the place where the gonads will form.
|
7 | Q24326 (/IMP) Q64729 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
7 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q90ZK6 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
7 | A0A087RK12 (/ISS) A0A087VDQ2 (/ISS) G1NF73 (/ISS) G3X8L8 (/ISS) H0YZF5 (/ISS) R0LPX2 (/ISS) U3K3F2 (/ISS) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
7 | A0A087RK12 (/ISS) A0A087VDQ2 (/ISS) G1NF73 (/ISS) G3X8L8 (/ISS) H0YZF5 (/ISS) R0LPX2 (/ISS) U3K3F2 (/ISS) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
7 | O35607 (/ISO) P27038 (/ISO) P27040 (/ISO) P36895 (/ISO) P36898 (/ISO) P37172 (/ISO) Q61288 (/ISO) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
7 | A1Z7L8 (/IMP) A1Z7L9 (/IMP) P50488 (/IMP) Q13873 (/IMP) Q23975 (/IMP) Q7YU60 (/IMP) Q8ITX8 (/IMP) |
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
7 | F1NCI7 (/IMP) P27037 (/IMP) P36896 (/IMP) Q04771 (/IMP) Q13705 (/IMP) Q90669 (/IMP) Q90670 (/IMP) |
Defense response to Gram-negative bacterium GO:0050829
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism.
|
7 | A0A0B4K7J3 (/IMP) P20792 (/IMP) Q7JPM7 (/IMP) Q7JPN8 (/IMP) Q7JQ36 (/IMP) Q7JQ39 (/IMP) Q95U21 (/IMP) |
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
|
6 | P36895 (/IMP) P37172 (/IMP) Q61271 (/IMP) Q61288 (/IMP) Q62312 (/IMP) Q64729 (/IMP) |
Compound eye morphogenesis GO:0001745
The morphogenetic process in which the anatomical structures of the compound eye are generated and organized. The adult compound eye is a precise assembly of 700-800 ommatidia. Each ommatidium is composed of 20 cells, identified by cell type and position. An example of compound eye morphogenesis is found in Drosophila melanogaster.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Morphogenesis of a branching structure GO:0001763
The process in which the anatomical structures of branches are generated and organized. A branch is a division or offshoot from a main stem. Examples in animals would include blood vessels, nerves, lymphatics and other endothelial or epithelial tubes.
|
6 | Q24326 (/NAS) Q7JQ37 (/NAS) Q7KTP1 (/NAS) Q8IPK9 (/NAS) Q95SI0 (/NAS) Q9VMT1 (/NAS) |
Regulation of transcription from RNA polymerase II promoter GO:0006357
Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
6 | P38444 (/TAS) P38445 (/TAS) P80201 (/TAS) P80202 (/TAS) P80203 (/TAS) Q62312 (/TAS) |
Actin filament organization GO:0007015
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking.
|
6 | A0A0B4K7J3 (/IMP) Q7JPM7 (/IMP) Q7JPN8 (/IMP) Q7JQ36 (/IMP) Q7JQ39 (/IMP) Q95U21 (/IMP) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
6 | Q24326 (/IPI) Q7JQ37 (/IPI) Q7KTP1 (/IPI) Q8IPK9 (/IPI) Q95SI0 (/IPI) Q9VMT1 (/IPI) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
6 | P36894 (/TAS) P36897 (/TAS) P36898 (/TAS) P37172 (/TAS) P37173 (/TAS) P38438 (/TAS) |
Transforming growth factor beta receptor complex assembly GO:0007181
The aggregation, arrangement and bonding together of a ligand-bound type II transforming growth factor beta (TGF-beta) receptor dimer with a type I TGF-beta receptor dimer, following ligand binding, to form a heterotetrameric TGF-beta receptor complex.
|
6 | Q24326 (/NAS) Q7JQ37 (/NAS) Q7KTP1 (/NAS) Q8IPK9 (/NAS) Q95SI0 (/NAS) Q9VMT1 (/NAS) |
Ovarian nurse cell to oocyte transport GO:0007300
Transfer of constituents synthesized in the ovarian nurse cells to the oocyte, through the ring canals, as the egg chamber is growing. An example of this is found in Drosophila melanogaster.
|
6 | A0A0B4K7J3 (/TAS) Q7JPM7 (/TAS) Q7JPN8 (/TAS) Q7JQ36 (/TAS) Q7JQ39 (/TAS) Q95U21 (/TAS) |
Open tracheal system development GO:0007424
The process whose specific outcome is the progression of an open tracheal system over time, from its formation to the mature structure. An open tracheal system is a respiratory system, a branched network of epithelial tubes that supplies oxygen to target tissues via spiracles. An example of this is found in Drosophila melanogaster.
|
6 | Q24326 (/NAS) Q7JQ37 (/NAS) Q7KTP1 (/NAS) Q8IPK9 (/NAS) Q95SI0 (/NAS) Q9VMT1 (/NAS) |
Imaginal disc-derived wing morphogenesis GO:0007476
The process in which the anatomical structures of the imaginal disc-derived wing are generated and organized. The wing is an appendage modified for flying.
|
6 | Q24326 (/IGI) Q7JQ37 (/IGI) Q7KTP1 (/IGI) Q8IPK9 (/IGI) Q95SI0 (/IGI) Q9VMT1 (/IGI) |
Histoblast morphogenesis GO:0007488
The process in which the anatomical structures derived from the histoblast disc are generated and organized. This includes the transformation of histoblast cells into adult structures during pupal metamorphosis. Histoblast cells are cells founded in the embryo that are the progenitors to the adult abdomen.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
6 | P27040 (/IMP) P36895 (/IMP) P37172 (/IMP) Q62312 (/IMP) Q64729 (/IMP) Q90ZK6 (/IMP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
6 | Q24326 (/TAS) Q7JQ37 (/TAS) Q7KTP1 (/TAS) Q8IPK9 (/TAS) Q95SI0 (/TAS) Q9VMT1 (/TAS) |
Determination of adult lifespan GO:0008340
The control of viability and duration in the adult phase of the life-cycle.
|
6 | A1Z7L8 (/IMP) A1Z7L9 (/IMP) P20792 (/IMP) P50488 (/IMP) Q23975 (/IMP) Q7YU60 (/IMP) |
Maternal determination of anterior/posterior axis, embryo GO:0008358
The specification of the anterior/posterior axis of the embryo by gradients of maternally-transcribed gene products; exemplified in insects by the morphogens, bicoid and nanos.
|
6 | A0A0B4K7J3 (/IGI) Q7JPM7 (/IGI) Q7JPN8 (/IGI) Q7JQ36 (/IGI) Q7JQ39 (/IGI) Q95U21 (/IGI) |
Maternal determination of anterior/posterior axis, embryo GO:0008358
The specification of the anterior/posterior axis of the embryo by gradients of maternally-transcribed gene products; exemplified in insects by the morphogens, bicoid and nanos.
|
6 | A0A0B4K7J3 (/IMP) Q7JPM7 (/IMP) Q7JPN8 (/IMP) Q7JQ36 (/IMP) Q7JQ39 (/IMP) Q95U21 (/IMP) |
Regulation of synaptic growth at neuromuscular junction GO:0008582
Any process that modulates the frequency, rate or extent of synaptic growth at neuromuscular junctions.
|
6 | Q24326 (/IGI) Q7JQ37 (/IGI) Q7KTP1 (/IGI) Q8IPK9 (/IGI) Q95SI0 (/IGI) Q9VMT1 (/IGI) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
6 | O35607 (/IMP) O73736 (/IMP) P27040 (/IMP) P36895 (/IMP) Q13705 (/IMP) Q9DGI6 (/IMP) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
6 | O35607 (/ISO) P27038 (/ISO) P36895 (/ISO) P37172 (/ISO) Q61288 (/ISO) Q64729 (/ISO) |
Regulation of cell-cell adhesion GO:0022407
Any process that modulates the frequency, rate or extent of attachment of a cell to another cell.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
6 | O00238 (/IMP) P27037 (/IMP) P36894 (/IMP) Q04771 (/IMP) Q13705 (/IMP) Q13873 (/IMP) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
6 | O35607 (/ISO) P27038 (/ISO) P27040 (/ISO) P36895 (/ISO) P36898 (/ISO) P37172 (/ISO) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
6 | P38444 (/ISS) Q05438 (/ISS) Q13873 (/ISS) Q28043 (/ISS) Q28560 (/ISS) Q78EA7 (/ISS) |
Negative regulation of transforming growth factor beta receptor signaling pathway GO:0030512
Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
|
6 | A0A0B4K7J3 (/IDA) Q7JPM7 (/IDA) Q7JPN8 (/IDA) Q7JQ36 (/IDA) Q7JQ39 (/IDA) Q95U21 (/IDA) |
Negative regulation of transforming growth factor beta receptor signaling pathway GO:0030512
Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
|
6 | A0A0B4K7J3 (/IGI) Q7JPM7 (/IGI) Q7JPN8 (/IGI) Q7JQ36 (/IGI) Q7JQ39 (/IGI) Q95U21 (/IGI) |
Ovarian follicle cell development GO:0030707
The process that occurs during oogenesis involving the ovarian follicle cells, somatic cells which surround the germ cells of an ovary. An example of this is found in Drosophila melanogaster.
|
6 | A0A0B4K7J3 (/IMP) Q7JPM7 (/IMP) Q7JPN8 (/IMP) Q7JQ36 (/IMP) Q7JQ39 (/IMP) Q95U21 (/IMP) |
Spectrosome organization GO:0030721
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the spectrosome, a germline specific spherical organelle that is the precursor to the fusome.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Genital disc development GO:0035215
Progression of the genital imaginal disc over time, from its initial formation through to its metamorphosis to form the adult terminalia, comprising the entire set of internal and external genitalia and analia. Both sexes of Drosophila have a single genital disc formed from the female and male genital primordia, and the anal primordium. The anal primordium develops in both sexes, forming either male or female analia. However, only one of the genital primordia develops in each sex, forming either the male or the female genitalia.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Wing disc pattern formation GO:0035222
The process giving rise to the pattern of cell differentiation in the wing imaginal disc.
|
6 | A0A0B4K7J3 (/IMP) Q7JPM7 (/IMP) Q7JPN8 (/IMP) Q7JQ36 (/IMP) Q7JQ39 (/IMP) Q95U21 (/IMP) |
Regulation of imaginal disc growth GO:0045570
Any process that modulates the frequency, rate or extent of the growth of the imaginal disc.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Regulation of cell differentiation GO:0045595
Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
6 | O00238 (/IMP) P27037 (/IMP) P36894 (/IMP) Q04771 (/IMP) Q13705 (/IMP) Q13873 (/IMP) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
6 | O35607 (/ISO) P27038 (/ISO) P27040 (/ISO) P36895 (/ISO) P36898 (/ISO) P37172 (/ISO) |
Negative regulation of innate immune response GO:0045824
Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response.
|
6 | A0A0B4K7J3 (/IMP) Q7JPM7 (/IMP) Q7JPN8 (/IMP) Q7JQ36 (/IMP) Q7JQ39 (/IMP) Q95U21 (/IMP) |
Positive regulation of growth GO:0045927
Any process that activates or increases the rate or extent of growth, the increase in size or mass of all or part of an organism.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
6 | O35607 (/ISO) P27038 (/ISO) P36895 (/ISO) P36898 (/ISO) P37172 (/ISO) Q61288 (/ISO) |
Branched duct epithelial cell fate determination, open tracheal system GO:0046845
Allocation of a set number of cells to each primary branch in an open tracheal system, prior to the onset of cell migration. This establishes different domains of cells within the tracheal placode.
|
6 | Q24326 (/TAS) Q7JQ37 (/TAS) Q7KTP1 (/TAS) Q8IPK9 (/TAS) Q95SI0 (/TAS) Q9VMT1 (/TAS) |
Wing disc anterior/posterior pattern formation GO:0048100
The establishment, maintenance and elaboration of the anterior/posterior axis of the wing disc, a precursor to the wing.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Oogenesis GO:0048477
The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster.
|
6 | A0A0B4K7J3 (/IMP) Q7JPM7 (/IMP) Q7JPN8 (/IMP) Q7JQ36 (/IMP) Q7JQ39 (/IMP) Q95U21 (/IMP) |
Positive regulation of muscle organ development GO:0048636
Any process that activates, maintains or increases the rate of muscle development.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Transforming growth factor beta receptor signaling pathway involved in endodermal cell fate specification GO:0060799
The series of molecular signals generated as a consequence of a transforming growth factor beta receptor binding to one of its physiological ligands and ultimately resulting in the commitment of an unspecified fate to adopt an endoderm fate.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Artery development GO:0060840
The progression of the artery over time, from its initial formation to the mature structure. An artery is a blood vessel that carries blood away from the heart to a capillary bed.
|
6 | F1QH44 (/IMP) O35607 (/IMP) P27040 (/IMP) Q498X0 (/IMP) Q61288 (/IMP) Q8JFB0 (/IMP) |
Anterior Malpighian tubule development GO:0061327
The process whose specific outcome is the progression of the anterior Malpighian tubule over time, from its formation to the mature structure. The pair of anterior tubules arise from a dorsal region of the embryonic hindgut and projects forwards through the body cavity. A Malpighian tubule is a fine, thin-walled excretory tubule in insects which connects with the posterior part of the gut.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
6 | A4FUX2 (/IDA) O46680 (/IDA) P36897 (/IDA) P37023 (/IDA) Q61288 (/IDA) Q64729 (/IDA) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
6 | O00238 (/IMP) P27037 (/IMP) P36894 (/IMP) P37023 (/IMP) Q04771 (/IMP) Q13873 (/IMP) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
6 | O35607 (/ISO) P27038 (/ISO) P36895 (/ISO) P36898 (/ISO) P37172 (/ISO) Q61288 (/ISO) |
Cell elongation involved in imaginal disc-derived wing morphogenesis GO:0090254
The process in which a cell elongates and contributes to imaginal disc-derived wing morphogenesis.
|
6 | Q24326 (/IMP) Q7JQ37 (/IMP) Q7KTP1 (/IMP) Q8IPK9 (/IMP) Q95SI0 (/IMP) Q9VMT1 (/IMP) |
Vasculature development GO:0001944
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
|
5 | F1QH44 (/IMP) O73736 (/IMP) Q498X0 (/IMP) Q8JFB0 (/IMP) Q9DGI6 (/IMP) |
Lymph vessel development GO:0001945
The process whose specific outcome is the progression of a lymph vessel over time, from its formation to the mature structure.
|
5 | A0A0R4IZG7 (/IGI) B3DJG0 (/IGI) O93243 (/IGI) Q1RLX1 (/IGI) Q66HY1 (/IGI) |
Lymph vessel development GO:0001945
The process whose specific outcome is the progression of a lymph vessel over time, from its formation to the mature structure.
|
5 | B0V0H4 (/IMP) B3DIP3 (/IMP) F1QXI5 (/IMP) Q288P2 (/IMP) Q288P3 (/IMP) |
Sprouting angiogenesis GO:0002040
The extension of new blood vessels from existing capillaries into avascular tissues resulting from the proliferation of blood vessel endothelial cells.
|
5 | B0V0H4 (/IGI) B3DIP3 (/IGI) F1QXI5 (/IGI) Q288P2 (/IGI) Q288P3 (/IGI) |
Peptidyl-threonine phosphorylation GO:0018107
The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
5 | P36896 (/IDA) P36897 (/IDA) P37173 (/IDA) Q04771 (/IDA) Q61271 (/IDA) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
5 | P36895 (/IDA) P36897 (/IDA) P37023 (/IDA) Q04771 (/IDA) Q06900 (/IDA) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
5 | F1QH44 (/IDA) O73736 (/IDA) Q498X0 (/IDA) Q8JFB0 (/IDA) Q9DGI6 (/IDA) |
Notochord morphogenesis GO:0048570
The process in which the anatomical structures of the notochord are generated and organized. The notochord is a mesoderm-derived structure located ventral of the developing nerve cord. In vertebrates, the notochord serves as a core around which other mesodermal cells form the vertebrae. In the most primitive chordates, which lack vertebrae, the notochord persists as a substitute for a vertebral column.
|
5 | B0V0H4 (/IMP) B3DIP3 (/IMP) F1QXI5 (/IMP) Q288P2 (/IMP) Q288P3 (/IMP) |
Protein homooligomerization GO:0051260
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
5 | B3DJG0 (/IDA) O73736 (/IDA) O93243 (/IDA) Q1RLX1 (/IDA) Q9DGI6 (/IDA) |
Ventricular septum morphogenesis GO:0060412
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
|
5 | P36897 (/ISS) P37173 (/ISS) Q04771 (/ISS) Q13873 (/ISS) Q90ZK6 (/ISS) |
Cardiac cell fate specification GO:0060912
The process involved in the specification of cardiac cell identity. Once specification has taken place, a cell will be committed to differentiate down a specific pathway if left in its normal environment.
|
5 | A0A0R4IZG7 (/IGI) B3DJG0 (/IGI) O93243 (/IGI) Q1RLX1 (/IGI) Q66HY1 (/IGI) |
Left/right pattern formation GO:0060972
The pattern specification process that results in the subdivision of the left/right axis in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.
|
5 | A0A0R4IZG7 (/IGI) B3DJG0 (/IGI) O93243 (/IGI) Q1RLX1 (/IGI) Q66HY1 (/IGI) |
Determination of heart left/right asymmetry GO:0061371
Determination of the asymmetric location of the heart with respect to the left and right halves of the organism.
|
5 | A0A0R4IZG7 (/IGI) B3DJG0 (/IGI) O93243 (/IGI) Q1RLX1 (/IGI) Q66HY1 (/IGI) |
Determination of heart left/right asymmetry GO:0061371
Determination of the asymmetric location of the heart with respect to the left and right halves of the organism.
|
5 | B3DJG0 (/IMP) O73736 (/IMP) O93243 (/IMP) Q1RLX1 (/IMP) Q9DGI6 (/IMP) |
Endocardial cushion morphogenesis GO:0003203
The process in which the anatomical structure of the endocardial cushion is generated and organized. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
4 | P36894 (/ISS) P37023 (/ISS) Q04771 (/ISS) Q90ZK6 (/ISS) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
4 | P27040 (/ISO) Q61271 (/ISO) Q61288 (/ISO) Q64729 (/ISO) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
4 | F1LQC5 (/IMP) P80201 (/IMP) P80202 (/IMP) P80204 (/IMP) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
4 | P36896 (/IDA) P36897 (/IDA) P37023 (/IDA) Q13705 (/IDA) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
4 | P27040 (/ISO) Q61271 (/ISO) Q61288 (/ISO) Q64729 (/ISO) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
4 | P37172 (/ISO) Q61288 (/ISO) Q62312 (/ISO) Q64729 (/ISO) |
Regulation of mitotic cell cycle GO:0007346
Any process that modulates the rate or extent of progress through the mitotic cell cycle.
|
4 | A1Z7L8 (/IMP) A1Z7L9 (/IMP) Q23975 (/IMP) Q7YU60 (/IMP) |
Neuroblast proliferation GO:0007405
The expansion of a neuroblast population by cell division. A neuroblast is any cell that will divide and give rise to a neuron.
|
4 | A1Z7L8 (/IMP) A1Z7L9 (/IMP) Q23975 (/IMP) Q7YU60 (/IMP) |
Ventral cord development GO:0007419
The process whose specific outcome is the progression of the ventral cord over time, from its formation to the mature structure. The ventral cord is one of the distinguishing traits of the central nervous system of all arthropods (such as insects, crustaceans and arachnids) as well as many other invertebrates, such as the annelid worms.
|
4 | M9PE88 (/IMP) Q95V83 (/IMP) Q9NGX8 (/IMP) Q9VZI9 (/IMP) |
Primary branching, open tracheal system GO:0007428
Formation of primary branches in the open tracheal system. These form from small groups of cells that migrate out at specific positions, organizing into tubes as they migrate. An example of this is found in Drosophila melanogaster.
|
4 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) Q95T01 (/IMP) |
Malpighian tubule morphogenesis GO:0007443
The process in which the anatomical structures of the Malpighian tubule are generated and organized. This process takes place entirely during the embryonic phase. A Malpighian tubule is a fine, thin-walled excretory tubule in insects which leads into the posterior part of the gut.
|
4 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) Q95T01 (/IMP) |
Eye-antennal disc morphogenesis GO:0007455
The process in which the anatomical structures derived from the eye-antennal disc are generated and organized. This includes the transformation of an eye-antennal imaginal disc from a monolayered epithelium in the larvae of holometabolous insects into recognizable adult structures including the eye, antenna, head capsule and maxillary palps.
|
4 | A1Z7L8 (/IGI) A1Z7L9 (/IGI) Q23975 (/IGI) Q7YU60 (/IGI) |
Neuromuscular junction development GO:0007528
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a neuromuscular junction.
|
4 | M9PE88 (/IMP) Q95V83 (/IMP) Q9NGX8 (/IMP) Q9VZI9 (/IMP) |
Head involution GO:0008258
Movement of the anterior ectoderm to the interior of the embryo.
|
4 | A0A0B4KG59 (/IMP) Q24229 (/IMP) Q24468 (/IMP) Q95T01 (/IMP) |
Regulation of synaptic growth at neuromuscular junction GO:0008582
Any process that modulates the frequency, rate or extent of synaptic growth at neuromuscular junctions.
|
4 | M9PE88 (/IMP) Q95V83 (/IMP) Q9NGX8 (/IMP) Q9VZI9 (/IMP) |
Response to UV GO:0009411
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers.
|
4 | A1Z7L8 (/IDA) A1Z7L9 (/IDA) Q23975 (/IDA) Q7YU60 (/IDA) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
4 | O35607 (/IGI) P27038 (/IGI) P27040 (/IGI) Q64729 (/IGI) |
Negative regulation of autophagy GO:0010507
Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
|
4 | A1Z7L8 (/IMP) A1Z7L9 (/IMP) Q23975 (/IMP) Q7YU60 (/IMP) |
Mushroom body development GO:0016319
The process whose specific outcome is the progression of the mushroom body over time, from its formation to the mature structure. The mushroom body is composed of the prominent neuropil structures of the insect central brain, thought to be crucial for olfactory associated learning. These consist mainly of a bulbous calyx and tightly packaged arrays of thin parallel fibers of the Kenyon cells.
|
4 | A1Z7L8 (/IMP) A1Z7L9 (/IMP) Q23975 (/IMP) Q7YU60 (/IMP) |
Peptidyl-threonine phosphorylation GO:0018107
The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
4 | P37172 (/ISO) Q61271 (/ISO) Q62312 (/ISO) Q64729 (/ISO) |
Proteoglycan biosynthetic process GO:0030166
The chemical reactions and pathways resulting in the formation of proteoglycans, any glycoprotein in which the carbohydrate units are glycosaminoglycans.
|
4 | F1NTD3 (/IMP) F6RIN4 (/IMP) O42124 (/IMP) Q05438 (/IMP) |
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
4 | P27038 (/ISO) P27040 (/ISO) P37172 (/ISO) Q61271 (/ISO) |
Positive regulation of multicellular organism growth GO:0040018
Any process that activates or increases the frequency, rate or extent of growth of an organism to reach its usual body size.
|
4 | A1Z7L8 (/TAS) A1Z7L9 (/TAS) Q23975 (/TAS) Q7YU60 (/TAS) |
Germ-line stem cell division GO:0042078
The self-renewing division of a germline stem cell to produce a daughter stem cell and a daughter germ cell, which will divide to form the gametes.
|
4 | A0A0B4KG59 (/TAS) Q24229 (/TAS) Q24468 (/TAS) Q95T01 (/TAS) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
4 | Q06900 (/IMP) Q61288 (/IMP) Q90ZK6 (/IMP) Q95L23 (/IMP) |
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
4 | P36894 (/ISS) P37023 (/ISS) Q04771 (/ISS) Q13873 (/ISS) |
Lateral inhibition GO:0046331
Signaling between cells of equivalent developmental potential that results in these cells adopting different developmental fates. An example is the suppression by cells with a particular fate of the adoption of the same fate by surrounding cells.
|
4 | M9PE88 (/IMP) Q95V83 (/IMP) Q9NGX8 (/IMP) Q9VZI9 (/IMP) |
Blood vessel morphogenesis GO:0048514
The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
|
4 | F1QH44 (/IMP) Q498X0 (/IMP) Q61288 (/IMP) Q8JFB0 (/IMP) |
Artery morphogenesis GO:0048844
The process in which the anatomical structures of arterial blood vessels are generated and organized. Arteries are blood vessels that transport blood from the heart to the body and its organs.
|
4 | F1QH44 (/IMP) Q498X0 (/IMP) Q64729 (/IMP) Q8JFB0 (/IMP) |
Palate development GO:0060021
The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
|
4 | P27040 (/IMP) P36895 (/IMP) Q62312 (/IMP) Q64729 (/IMP) |
Endochondral bone morphogenesis GO:0060350
The process in which bones are generated and organized as a result of the conversion of initial cartilaginous anlage into bone.
|
4 | F1NTD3 (/IMP) F6RIN4 (/IMP) O42124 (/IMP) Q05438 (/IMP) |
Ventricular septum morphogenesis GO:0060412
The developmental process in which a ventricular septum is generated and organized. A ventricular septum is an anatomical structure that separates the lower chambers (ventricles) of the heart from one another.
|
4 | O35607 (/IMP) P37172 (/IMP) Q62312 (/IMP) Q64729 (/IMP) |
Lymphatic endothelial cell differentiation GO:0060836
The process in which a venous blood vessel endothelial cell acquires specialized features of a lymphatic vessel endothelial cell, a thin flattened cell that lines the inside surfaces of lymph vessels.
|
4 | O35607 (/IMP) P27040 (/IMP) P37023 (/IMP) Q61288 (/IMP) |
Positive regulation of cartilage development GO:0061036
Any process that increases the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
4 | F1NTD3 (/IMP) F6RIN4 (/IMP) O42124 (/IMP) Q05438 (/IMP) |
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
4 | P36897 (/IDA) P37173 (/IDA) Q62312 (/IDA) Q64729 (/IDA) |
Negative regulation of transforming growth factor beta activation GO:1901389
Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor beta activation.
|
4 | F1NCI7 (/IMP) K7GLP5 (/IMP) Q66T47 (/IMP) Q90670 (/IMP) |
Positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO:1905007
Any process that activates or increases the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation.
|
4 | P36897 (/ISS) P37173 (/ISS) Q04771 (/ISS) Q90ZK6 (/ISS) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
3 | P37023 (/IMP) Q61288 (/IMP) Q64729 (/IMP) |
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
|
3 | F1QH44 (/IMP) Q498X0 (/IMP) Q8JFB0 (/IMP) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
3 | P38438 (/IEP) P80203 (/IEP) P80204 (/IEP) |
Mesoderm formation GO:0001707
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
3 | O35607 (/IMP) P36895 (/IMP) P37172 (/IMP) |
Lymphangiogenesis GO:0001946
Lymph vessel formation when new vessels emerge from the proliferation of pre-existing vessels.
|
3 | O35607 (/IMP) P27040 (/IMP) Q61288 (/IMP) |
Lymphangiogenesis GO:0001946
Lymph vessel formation when new vessels emerge from the proliferation of pre-existing vessels.
|
3 | P37023 (/ISS) Q13705 (/ISS) Q13873 (/ISS) |
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
|
3 | O35607 (/IMP) P27040 (/IMP) Q61288 (/IMP) |
Blood vessel remodeling GO:0001974
The reorganization or renovation of existing blood vessels.
|
3 | P37023 (/ISS) Q13705 (/ISS) Q13873 (/ISS) |
Chondrocyte development GO:0002063
The process whose specific outcome is the progression of a chondrocyte over time, from its commitment to its mature state. Chondrocyte development does not include the steps involved in committing a chondroblast to a chondrocyte fate.
|
3 | F1NTD3 (/IMP) Q05438 (/IMP) Q13873 (/IMP) |
Embryonic heart tube morphogenesis GO:0003143
The process in which the anatomical structures of the embryonic heart tube are generated and organized. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
|
3 | O73736 (/IMP) Q04771 (/IMP) Q9DGI6 (/IMP) |
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
|
3 | O35607 (/IMP) P36895 (/IMP) Q62312 (/IMP) |
Outflow tract septum morphogenesis GO:0003148
The process in which the anatomical structures of the outflow tract septum are generated and organized. The outflow tract septum is a partition in the outflow tract.
|
3 | P36894 (/ISS) P37173 (/ISS) Q13873 (/ISS) |
Outflow tract morphogenesis GO:0003151
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
|
3 | O35607 (/IMP) P36895 (/IMP) Q62312 (/IMP) |
Outflow tract morphogenesis GO:0003151
The process in which the anatomical structures of the outflow tract are generated and organized. The outflow tract is the portion of the heart through which blood flows into the arteries.
|
3 | P36894 (/ISS) P37173 (/ISS) Q13873 (/ISS) |
Atrioventricular valve morphogenesis GO:0003181
The process in which the structure of the atrioventricular valve is generated and organized.
|
3 | P37173 (/ISS) Q04771 (/ISS) Q90ZK6 (/ISS) |
Mitral valve morphogenesis GO:0003183
The process in which the structure of the mitral valve is generated and organized.
|
3 | O35607 (/IMP) P36895 (/IMP) Q04771 (/IMP) |
Tricuspid valve morphogenesis GO:0003186
The process in which the structure of the tricuspid valve is generated and organized.
|
3 | O35607 (/IMP) P36895 (/IMP) Q62312 (/IMP) |
Tricuspid valve morphogenesis GO:0003186
The process in which the structure of the tricuspid valve is generated and organized.
|
3 | P36894 (/ISS) P37173 (/ISS) Q13873 (/ISS) |
Endocardial cushion morphogenesis GO:0003203
The process in which the anatomical structure of the endocardial cushion is generated and organized. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
3 | P36895 (/IMP) P37172 (/IMP) Q61288 (/IMP) |
Endocardial cushion fusion GO:0003274
The cell-cell adhesion process of mesenchymal cardiac cushion cells that contributes to the process of cushion shaping.
|
3 | P37173 (/ISS) Q04771 (/ISS) Q90ZK6 (/ISS) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
3 | P36896 (/IDA) P36897 (/IDA) Q13705 (/IDA) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
3 | Q06900 (/ISA) Q90999 (/ISA) Q90ZK6 (/ISA) |
Transmembrane receptor protein serine/threonine kinase signaling pathway GO:0007178
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses serine/threonine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | P27037 (/TAS) P36896 (/TAS) Q13705 (/TAS) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | Q06900 (/ISA) Q90999 (/ISA) Q90ZK6 (/ISA) |
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
3 | O73736 (/IMP) Q62312 (/IMP) Q9DGI6 (/IMP) |
Cell proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
3 | F1NCI7 (/IMP) Q90669 (/IMP) Q90670 (/IMP) |
Regulation of signal transduction GO:0009966
Any process that modulates the frequency, rate or extent of signal transduction.
|
3 | P27038 (/IDA) P27040 (/IDA) Q61271 (/IDA) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
3 | Q06900 (/IMP) Q62312 (/IMP) Q64729 (/IMP) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
3 | P36894 (/IDA) P36897 (/IDA) Q04771 (/IDA) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
3 | P38438 (/IEP) P70539 (/IEP) P80204 (/IEP) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
3 | P36896 (/IDA) P37023 (/IDA) Q13873 (/IDA) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
3 | O35607 (/ISO) Q61271 (/ISO) Q61288 (/ISO) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
3 | P38438 (/IEP) P80204 (/IEP) Q90999 (/IEP) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
3 | P36894 (/IC) P50488 (/IC) Q8ITX8 (/IC) |
Regulation of BMP signaling pathway GO:0030510
Any process that modulates the frequency, rate or extent of the activity of any BMP receptor signaling pathway.
|
3 | O73736 (/IMP) P27038 (/IMP) Q9DGI6 (/IMP) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
3 | P37023 (/IDA) Q61288 (/IDA) Q90ZK6 (/IDA) |
Positive regulation of activin receptor signaling pathway GO:0032927
Any process that activates or increases the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
3 | P27037 (/IDA) P36896 (/IDA) Q13705 (/IDA) |
Positive regulation of activin receptor signaling pathway GO:0032927
Any process that activates or increases the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
3 | P27038 (/ISO) P27040 (/ISO) Q61271 (/ISO) |
Response to fluid shear stress GO:0034405
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.
|
3 | F1QH44 (/IMP) Q498X0 (/IMP) Q8JFB0 (/IMP) |
Embryonic hemopoiesis GO:0035162
The stages of blood cell formation that take place within the embryo.
|
3 | O73736 (/IMP) Q62312 (/IMP) Q9DGI6 (/IMP) |
Dauer larval development GO:0040024
The process whose specific outcome is the progression of the dauer larva over time, through the facultative diapause of the dauer (enduring) larval stage, with specialized traits adapted for dispersal and long-term survival, with elevated stress resistance and without feeding.
|
3 | P20792 (/IGI) P50488 (/IGI) Q8ITX8 (/IGI) |
Dauer larval development GO:0040024
The process whose specific outcome is the progression of the dauer larva over time, through the facultative diapause of the dauer (enduring) larval stage, with specialized traits adapted for dispersal and long-term survival, with elevated stress resistance and without feeding.
|
3 | P20792 (/IMP) P50488 (/IMP) Q8ITX8 (/IMP) |
Blood vessel endothelial cell migration GO:0043534
The orderly movement of an endothelial cell into the extracellular matrix in order to form new blood vessels during angiogenesis.
|
3 | F1QH44 (/IMP) Q498X0 (/IMP) Q8JFB0 (/IMP) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
3 | P37172 (/ISO) Q61288 (/ISO) Q64729 (/ISO) |
Mesodermal cell differentiation GO:0048333
The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell.
|
3 | F1NCI7 (/IMP) Q90669 (/IMP) Q90670 (/IMP) |
Lateral mesoderm development GO:0048368
The process whose specific outcome is the progression of the lateral mesoderm over time, from its formation to the mature structure.
|
3 | O73736 (/IMP) P36895 (/IMP) Q9DGI6 (/IMP) |
Blood vessel morphogenesis GO:0048514
The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.
|
3 | F1QH44 (/IGI) Q498X0 (/IGI) Q8JFB0 (/IGI) |
Mesenchymal cell differentiation GO:0048762
The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
|
3 | Q06900 (/IMP) Q90999 (/IMP) Q90ZK6 (/IMP) |
Regulation of blood vessel size GO:0050880
Any process that modulates the size of blood vessels.
|
3 | F1QH44 (/IMP) Q498X0 (/IMP) Q8JFB0 (/IMP) |
Hematopoietic stem cell differentiation GO:0060218
The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
|
3 | F1QKF4 (/IGI) Q58EQ1 (/IGI) Q7ZZU8 (/IGI) |
Hematopoietic stem cell differentiation GO:0060218
The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
|
3 | F1QKF4 (/IMP) Q58EQ1 (/IMP) Q7ZZU8 (/IMP) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
3 | P36897 (/IDA) P37173 (/IDA) Q04771 (/IDA) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
3 | P37172 (/ISO) Q62312 (/ISO) Q64729 (/ISO) |
Artery development GO:0060840
The progression of the artery over time, from its initial formation to the mature structure. An artery is a blood vessel that carries blood away from the heart to a capillary bed.
|
3 | F1QH44 (/IGI) Q498X0 (/IGI) Q8JFB0 (/IGI) |
Artery development GO:0060840
The progression of the artery over time, from its initial formation to the mature structure. An artery is a blood vessel that carries blood away from the heart to a capillary bed.
|
3 | P37023 (/ISS) Q13705 (/ISS) Q13873 (/ISS) |
Venous blood vessel development GO:0060841
The progression of the venous blood vessel over time from its initial formation to the mature structure. Venous blood vessels carry blood back to the heart after the capillary bed.
|
3 | O35607 (/IMP) P27040 (/IMP) Q61288 (/IMP) |
Venous blood vessel development GO:0060841
The progression of the venous blood vessel over time from its initial formation to the mature structure. Venous blood vessels carry blood back to the heart after the capillary bed.
|
3 | P37023 (/ISS) Q13705 (/ISS) Q13873 (/ISS) |
Left/right pattern formation GO:0060972
The pattern specification process that results in the subdivision of the left/right axis in space to define an area or volume in which specific patterns of cell differentiation will take place or in which cells interpret a specific environment.
|
3 | B3DJG0 (/IMP) O93243 (/IMP) Q1RLX1 (/IMP) |
Retina vasculature development in camera-type eye GO:0061298
The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure.
|
3 | O35607 (/IMP) P27040 (/IMP) Q61288 (/IMP) |
Retina vasculature development in camera-type eye GO:0061298
The process whose specific outcome is the progression of the vasculature of the retina over time, from its formation to the mature structure.
|
3 | P37023 (/ISS) Q13705 (/ISS) Q13873 (/ISS) |
Negative regulation of chondrocyte proliferation GO:1902731
Any process that stops, prevents, or reduces the frequency, rate or extent of the multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage.
|
3 | F1NTD3 (/IMP) Q05438 (/IMP) Q13873 (/IMP) |
Positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation GO:1905007
Any process that activates or increases the frequency, rate or extent of epithelial to mesenchymal transition involved in endocardial cushion formation.
|
3 | P37172 (/IMP) Q62312 (/IMP) Q64729 (/IMP) |
G1/S transition of mitotic cell cycle GO:0000082
The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.
|
2 | P37172 (/ISO) Q61271 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
2 | P27040 (/IGI) Q64729 (/IGI) |
Branching involved in blood vessel morphogenesis GO:0001569
The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
|
2 | P37172 (/IMP) Q62312 (/IMP) |
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
|
2 | P36897 (/ISS) Q28041 (/ISS) |
Gastrulation with mouth forming second GO:0001702
A gastrulation process in which the initial invagination becomes the anus and the mouth forms second.
|
2 | P27038 (/IGI) P27040 (/IGI) |
Endoderm formation GO:0001706
The formation of the endoderm during gastrulation.
|
2 | B3DJ37 (/IDA) P79689 (/IDA) |
Endoderm formation GO:0001706
The formation of the endoderm during gastrulation.
|
2 | B3DJ37 (/IGI) P79689 (/IGI) |
Mesoderm formation GO:0001707
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
2 | B3DJ37 (/IDA) P79689 (/IDA) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
2 | P27040 (/IGI) Q64729 (/IGI) |
Liver development GO:0001889
The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
2 | Q06900 (/IMP) Q13873 (/IMP) |
Vasculature development GO:0001944
The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism.
|
2 | F1QXI5 (/IGI) Q288P3 (/IGI) |
Positive regulation of mesenchymal cell proliferation GO:0002053
The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
|
2 | P36895 (/IMP) Q62312 (/IMP) |
Lens development in camera-type eye GO:0002088
The process whose specific outcome is the progression of the lens over time, from its formation to the mature structure. The lens is a transparent structure in the eye through which light is focused onto the retina. An example of this process is found in Mus musculus.
|
2 | Q62312 (/IMP) Q64729 (/IMP) |
Nematode larval development GO:0002119
The process whose specific outcome is the progression of the nematode larva over time, from its formation to the mature structure. Nematode larval development begins with the newly hatched first-stage larva (L1) and ends with the end of the last larval stage (for example the fourth larval stage (L4) in C. elegans). Each stage of nematode larval development is characterized by proliferation of specific cell lineages and an increase in body size without alteration of the basic body plan. Nematode larval stages are separated by molts in which each stage-specific exoskeleton, or cuticle, is shed and replaced anew.
|
2 | P50488 (/IMP) Q8ITX8 (/IMP) |
Determination of left/right asymmetry in lateral mesoderm GO:0003140
The establishment of the lateral mesoderm with respect to the left and right halves.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Atrioventricular valve morphogenesis GO:0003181
The process in which the structure of the atrioventricular valve is generated and organized.
|
2 | P37172 (/IMP) Q62312 (/IMP) |
Mitral valve morphogenesis GO:0003183
The process in which the structure of the mitral valve is generated and organized.
|
2 | P36894 (/ISS) Q13873 (/ISS) |
Ventricular trabecula myocardium morphogenesis GO:0003222
The process in which the anatomical structures of the trabecular cardiac ventricle muscle are generated and organized.
|
2 | P36895 (/IMP) Q64729 (/IMP) |
Ventricular trabecula myocardium morphogenesis GO:0003222
The process in which the anatomical structures of the trabecular cardiac ventricle muscle are generated and organized.
|
2 | P36894 (/ISS) P36897 (/ISS) |
Ventricular compact myocardium morphogenesis GO:0003223
The process in which the anatomical structures of the compact cardiac ventricle muscle are generated and organized.
|
2 | P36895 (/IMP) Q64729 (/IMP) |
Ventricular compact myocardium morphogenesis GO:0003223
The process in which the anatomical structures of the compact cardiac ventricle muscle are generated and organized.
|
2 | P36894 (/ISS) P36897 (/ISS) |
Cardiac atrium development GO:0003230
The process whose specific outcome is the progression of a cardiac atrium over time, from its formation to the mature structure. A cardiac atrium receives blood from a vein and pumps it to a cardiac ventricle.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Endocardial cushion fusion GO:0003274
The cell-cell adhesion process of mesenchymal cardiac cushion cells that contributes to the process of cushion shaping.
|
2 | P37172 (/IMP) Q62312 (/IMP) |
Atrial septum primum morphogenesis GO:0003289
The process in which anatomical structure of an atrial septum primum is generated and organized.
|
2 | P37172 (/IMP) Q04771 (/IMP) |
Proepicardium development GO:0003342
The progression of the proepicardium from its formation to the mature structure. The proepicardium is an outpouching of the septum transversum.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P36897 (/IMP) P37023 (/IMP) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
2 | P70539 (/IC) Q8NER5 (/IC) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P36897 (/IC) P37173 (/IC) |
Gastrulation GO:0007369
A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
|
2 | P37172 (/IMP) Q62312 (/IMP) |
Endodermal cell fate determination GO:0007493
The cell fate determination process in which a cell becomes capable of differentiating autonomously into an endoderm cell regardless of its environment; upon determination, the cell fate cannot be reversed.
|
2 | B3DJ37 (/IDA) P79689 (/IDA) |
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
2 | P27038 (/IMP) P37172 (/IMP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
2 | Q06900 (/IDA) Q90999 (/IDA) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Embryo implantation GO:0007566
Attachment of the blastocyst to the uterine lining.
|
2 | P38438 (/IEP) P80204 (/IEP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
2 | P38438 (/IEP) P80204 (/IEP) |
Positive regulation of cell proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P36897 (/IMP) Q95L23 (/IMP) |
Negative regulation of cell proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P37023 (/IMP) P38438 (/IMP) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
2 | P27038 (/IMP) Q64729 (/IMP) |
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
2 | P38438 (/IEP) P70539 (/IEP) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
2 | P27040 (/IMP) Q64729 (/IMP) |
Axis specification GO:0009798
The establishment, maintenance and elaboration of a pattern along a line or around a point.
|
2 | Q90669 (/IMP) Q90670 (/IMP) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
2 | P36897 (/ISS) Q13873 (/ISS) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
2 | P38438 (/IEP) P38444 (/IEP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | Q06900 (/IMP) Q61271 (/IMP) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | Q61271 (/IMP) Q61288 (/IMP) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | Q90999 (/IMP) Q90ZK6 (/IMP) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Regulation of lung blood pressure GO:0014916
The process that modulates the force with which blood travels through the lungs. The process is controlled by a balance of processes that increase pressure and decrease pressure.
|
2 | O35607 (/IMP) Q13873 (/IMP) |
Peptidyl-serine phosphorylation GO:0018105
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
|
2 | P36897 (/IDA) P37173 (/IDA) |
Peptidyl-serine phosphorylation GO:0018105
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
|
2 | Q62312 (/ISO) Q64729 (/ISO) |
Peptidyl-threonine phosphorylation GO:0018107
The phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Oviposition GO:0018991
The deposition of eggs (either fertilized or not) upon a surface or into a medium such as water.
|
2 | P50488 (/IMP) Q8ITX8 (/IMP) |
Central nervous system formation GO:0021556
The process that gives rise to the central nervous system. This process pertains to the initial formation of a structure from unspecified parts. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain, spinal cord and spinal nerves. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
2 | P70539 (/IDA) Q8NER5 (/IDA) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
2 | P36895 (/IGI) P36898 (/IGI) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
2 | P36895 (/IMP) Q62312 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | P37172 (/ISO) Q64729 (/ISO) |
Regulation of BMP signaling pathway GO:0030510
Any process that modulates the frequency, rate or extent of the activity of any BMP receptor signaling pathway.
|
2 | O73736 (/IGI) Q9DGI6 (/IGI) |
Negative regulation of transforming growth factor beta receptor signaling pathway GO:0030512
Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
|
2 | P36897 (/TAS) P37173 (/TAS) |
Positive regulation of BMP signaling pathway GO:0030513
Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
|
2 | O35607 (/ISO) Q61288 (/ISO) |
Larval feeding behavior GO:0030536
Feeding behavior in a larval (immature) organism.
|
2 | P20792 (/IMP) P50488 (/IMP) |
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
|
2 | P38438 (/IEP) P80204 (/IEP) |
Fin regeneration GO:0031101
The regrowth of fin tissue following its loss or destruction.
|
2 | B3DJ37 (/IMP) P79689 (/IMP) |
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
|
2 | P27040 (/IDA) Q62312 (/IDA) |
Positive regulation of chondrocyte differentiation GO:0032332
Any process that activates or increases the frequency, rate or extent of chondrocyte differentiation.
|
2 | O00238 (/ISS) P36898 (/ISS) |
Embryonic heart tube development GO:0035050
The process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure. The heart tube forms as the heart rudiment from the heart field.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Embryonic caudal fin morphogenesis GO:0035124
The process, occurring in the embryo, by which the anatomical structures of the caudal fin are generated and organized. The caudal fin is an unpaired medial fin mounted at the caudal end of the fish and is the main fin used for propulsion.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Determination of left/right asymmetry in diencephalon GO:0035462
The establishment of the diencephalon with respect to the left and right halves.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Intracellular signal transduction GO:0035556
The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.
|
2 | Q06900 (/IDA) Q90ZK6 (/IDA) |
Dorsal aorta morphogenesis GO:0035912
The process in which the anatomical structures of the dorsal aorta are generated and organized. The dorsal aorta is a blood vessel in a single-pass circulatory system that carries oxygenated blood from the gills to the rest of the body. In a single-pass circulatory system blood passes once through the heart to supply the body once.
|
2 | P36895 (/IMP) Q61288 (/IMP) |
Dorsal aorta morphogenesis GO:0035912
The process in which the anatomical structures of the dorsal aorta are generated and organized. The dorsal aorta is a blood vessel in a single-pass circulatory system that carries oxygenated blood from the gills to the rest of the body. In a single-pass circulatory system blood passes once through the heart to supply the body once.
|
2 | P36894 (/ISS) P37023 (/ISS) |
Nodal signaling pathway GO:0038092
A series of molecular signals initiated by the binding of a nodal protein to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | Q61271 (/ISO) Q8K348 (/ISO) |
Positive regulation of multicellular organism growth GO:0040018
Any process that activates or increases the frequency, rate or extent of growth of an organism to reach its usual body size.
|
2 | P50488 (/IMP) Q8ITX8 (/IMP) |
Endothelial cell activation GO:0042118
The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
2 | Q06900 (/IMP) Q90ZK6 (/IMP) |
Regulation of cell proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
2 | Q13873 (/IMP) Q62312 (/IMP) |
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
2 | P27040 (/IMP) P36895 (/IMP) |
Odontogenesis GO:0042476
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
|
2 | O73736 (/IEP) Q9DGI6 (/IEP) |
Odontogenesis GO:0042476
The process whose specific outcome is the progression of a tooth or teeth over time, from formation to the mature structure(s). A tooth is any hard bony, calcareous, or chitinous organ found in the mouth or pharynx of an animal and used in procuring or masticating food.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Dauer entry GO:0043053
Entry into the facultative diapause of the dauer (enduring) larval stage of nematode development.
|
2 | P20792 (/IGI) P50488 (/IGI) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | Q64729 (/IMP) Q95L23 (/IMP) |
Positive regulation of neuron apoptotic process GO:0043525
Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process.
|
2 | F1NCI7 (/IMP) Q90670 (/IMP) |
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
|
2 | P50488 (/IMP) Q8ITX8 (/IMP) |
Positive regulation of erythrocyte differentiation GO:0045648
Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
|
2 | P27037 (/IDA) P36896 (/IDA) |
Positive regulation of erythrocyte differentiation GO:0045648
Any process that activates or increases the frequency, rate or extent of erythrocyte differentiation.
|
2 | P27038 (/ISO) Q61271 (/ISO) |
Positive regulation of angiogenesis GO:0045766
Any process that activates or increases angiogenesis.
|
2 | Q61288 (/IGI) Q62312 (/IGI) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P37023 (/IDA) Q04771 (/IDA) |
Negative regulation of calcium-dependent cell-cell adhesion GO:0046588
Any process that stops, prevents, or reduces the frequency, rate or extent of calcium-dependent cell-cell adhesion.
|
2 | O73736 (/IDA) Q9DGI6 (/IDA) |
Negative regulation of calcium-dependent cell-cell adhesion GO:0046588
Any process that stops, prevents, or reduces the frequency, rate or extent of calcium-dependent cell-cell adhesion.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Determination of dorsal identity GO:0048263
Determination of the identity of part of an organism or organ where those parts are of the type that occur in the dorsal region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
2 | F1RC58 (/IMP) Q9W629 (/IMP) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Mesoderm morphogenesis GO:0048332
The process in which the anatomical structures of the mesoderm are generated and organized.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Digestive tract development GO:0048565
The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
|
2 | P38438 (/IEP) P80204 (/IEP) |
Embryonic cranial skeleton morphogenesis GO:0048701
The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase.
|
2 | Q62312 (/IMP) Q64729 (/IMP) |
Embryonic cranial skeleton morphogenesis GO:0048701
The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase.
|
2 | P36897 (/ISS) P37173 (/ISS) |
Skeletal system morphogenesis GO:0048705
The process in which the anatomical structures of the skeleton are generated and organized.
|
2 | P27040 (/IGI) Q64729 (/IGI) |
Mesenchymal cell differentiation GO:0048762
The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
|
2 | P36897 (/TAS) Q90999 (/TAS) |
Defense response to fungus GO:0050832
Reactions triggered in response to the presence of a fungus that act to protect the cell or organism.
|
2 | P50488 (/IMP) Q8ITX8 (/IMP) |
Positive regulation of stress fiber assembly GO:0051496
Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
|
2 | P36897 (/ISS) Q90999 (/ISS) |
Palate development GO:0060021
The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
|
2 | P27040 (/IGI) Q64729 (/IGI) |
Palate development GO:0060021
The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
|
2 | P36897 (/ISS) P37173 (/ISS) |
Dorsal convergence GO:0060030
The directed migration of individual cells and small groups of cells toward the dorsal midline during gastrulation. This process does not require cell rearrangement.
|
2 | O73736 (/IMP) Q9DGI6 (/IMP) |
Pharyngeal system development GO:0060037
The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
|
2 | P37172 (/IMP) Q64729 (/IMP) |
Pharyngeal system development GO:0060037
The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Regulation of cardiac muscle cell proliferation GO:0060043
Any process that modulates the frequency, rate or extent of cardiac muscle cell proliferation.
|
2 | P36895 (/IMP) Q64729 (/IMP) |
Regulation of cardiac muscle cell proliferation GO:0060043
Any process that modulates the frequency, rate or extent of cardiac muscle cell proliferation.
|
2 | P36894 (/ISS) P36897 (/ISS) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | Q06900 (/IMP) Q90ZK6 (/IMP) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Positive regulation of SMAD protein import into nucleus GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein import into the nucleus, i.e. the directed movement of a SMAD proteins from the cytoplasm into the nucleus. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P36894 (/IDA) P36897 (/IDA) |
Positive regulation of SMAD protein import into nucleus GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein import into the nucleus, i.e. the directed movement of a SMAD proteins from the cytoplasm into the nucleus. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P36895 (/ISO) Q64729 (/ISO) |
Lymphatic endothelial cell differentiation GO:0060836
The process in which a venous blood vessel endothelial cell acquires specialized features of a lymphatic vessel endothelial cell, a thin flattened cell that lines the inside surfaces of lymph vessels.
|
2 | Q13705 (/ISS) Q13873 (/ISS) |
Angiogenesis involved in coronary vascular morphogenesis GO:0060978
Blood vessel formation in the heart when new vessels emerge from the proliferation of pre-existing blood vessels.
|
2 | P36897 (/ISS) Q06900 (/ISS) |
Regulation of dauer larval development GO:0061065
Any process that modulates the rate, frequency, or extent of dauer larval development, the process whose specific outcome is the progression of the dauer larva over time, through the facultative diapause of the dauer (enduring) larval stage, with specialized traits adapted for dispersal and long-term survival, with elevated stress resistance and without feeding.
|
2 | P20792 (/IGI) P50488 (/IGI) |
Regulation of dauer larval development GO:0061065
Any process that modulates the rate, frequency, or extent of dauer larval development, the process whose specific outcome is the progression of the dauer larva over time, through the facultative diapause of the dauer (enduring) larval stage, with specialized traits adapted for dispersal and long-term survival, with elevated stress resistance and without feeding.
|
2 | P20792 (/IMP) P50488 (/IMP) |
Negative regulation of dauer larval development GO:0061067
Any process that decreases the rate, frequency, or extent of dauer larval development, the process whose specific outcome is the progression of the dauer larva over time, through the facultative diapause of the dauer (enduring) larval stage, with specialized traits adapted for dispersal and long-term survival, with elevated stress resistance and without feeding.
|
2 | P20792 (/IMP) P50488 (/IMP) |
BMP signaling pathway involved in heart development GO:0061312
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the progression of the heart over time.
|
2 | P36894 (/IC) P36895 (/IC) |
BMP signaling pathway involved in heart development GO:0061312
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the progression of the heart over time.
|
2 | Q04771 (/ISS) Q90ZK6 (/ISS) |
Cranial ganglion development GO:0061550
The process whose specific outcome is the progression of a cranial ganglion over time, from its formation to the mature structure.
|
2 | F1NCI7 (/IMP) Q90670 (/IMP) |
Pharyngeal arch artery morphogenesis GO:0061626
The process in which the anatomical structures of a pharyngeal arch artery is generated and organized. The pharyngeal arch arteries are a series of six paired embryological vascular structures, the development of which give rise to several major arteries, such as the stapedial artery, the middle meningeal artery, the internal carotid artery and the pulmonary artery.
|
2 | O35607 (/IMP) P36895 (/IMP) |
Pharyngeal arch artery morphogenesis GO:0061626
The process in which the anatomical structures of a pharyngeal arch artery is generated and organized. The pharyngeal arch arteries are a series of six paired embryological vascular structures, the development of which give rise to several major arteries, such as the stapedial artery, the middle meningeal artery, the internal carotid artery and the pulmonary artery.
|
2 | P36894 (/ISS) Q13873 (/ISS) |
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
2 | Q06900 (/ISA) Q90999 (/ISA) |
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
2 | Q62312 (/ISO) Q64729 (/ISO) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
2 | Q61288 (/ISO) Q64729 (/ISO) |
Regulation of eating behavior GO:1903998
Any process that modulates the frequency, rate or extent of eating behavior.
|
2 | P20792 (/IMP) P50488 (/IMP) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
2 | P36894 (/IMP) P36895 (/IMP) |
Positive regulation of occluding junction disassembly GO:1905075
Any process that activates or increases the frequency, rate or extent of occluding junction disassembly.
|
2 | P36897 (/ISS) Q90999 (/ISS) |
Epicardium morphogenesis GO:1905223
The developmental process by which an epicardium is generated and organized.
|
2 | P36897 (/ISS) Q06900 (/ISS) |
Negative regulation of DNA biosynthetic process GO:2000279
Any process that stops, prevents or reduces the frequency, rate or extent of DNA biosynthetic process.
|
2 | P37023 (/IMP) Q13873 (/IMP) |
Negative regulation of DNA biosynthetic process GO:2000279
Any process that stops, prevents or reduces the frequency, rate or extent of DNA biosynthetic process.
|
2 | O35607 (/ISO) Q61288 (/ISO) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
2 | P36897 (/IMP) Q04771 (/IMP) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
2 | Q06900 (/ISA) Q90ZK6 (/ISA) |
Negative regulation of extrinsic apoptotic signaling pathway GO:2001237
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
|
2 | P37172 (/ISO) Q64729 (/ISO) |
G1/S transition of mitotic cell cycle GO:0000082
The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.
|
1 | P36896 (/IDA) |
G1/S transition of mitotic cell cycle GO:0000082
The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.
|
1 | Q04771 (/IMP) |
G1/S transition of mitotic cell cycle GO:0000082
The mitotic cell cycle transition by which a cell in G1 commits to S phase. The process begins with the build up of G1 cyclin-dependent kinase (G1 CDK), resulting in the activation of transcription of G1 cyclins. The process ends with the positive feedback of the G1 cyclins on the G1 CDK which commits the cell to S phase, in which DNA replication is initiated.
|
1 | Q90ZK6 (/ISA) |
Negative regulation of transcription from RNA polymerase II promoter GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | Q13705 (/IGI) |
Negative regulation of transcription from RNA polymerase II promoter GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | P27040 (/ISO) |
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
1 | P36897 (/IDA) |
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
1 | Q06900 (/ISA) |
Activation of MAPKK activity GO:0000186
The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
|
1 | Q64729 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
1 | Q06900 (/ISA) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
1 | P36898 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
1 | P36897 (/ISS) |
Cartilage condensation GO:0001502
The condensation of mesenchymal cells that have been committed to differentiate into chondrocytes.
|
1 | P36898 (/IMP) |
Cartilage condensation GO:0001502
The condensation of mesenchymal cells that have been committed to differentiate into chondrocytes.
|
1 | O00238 (/NAS) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
1 | Q06900 (/ISA) |
Angiogenesis GO:0001525
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
|
1 | Q61288 (/ISO) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
1 | P70539 (/IEP) |
Ovarian cumulus expansion GO:0001550
Increase in size of the cumulus surrounding the oocyte including change in morphology due to proliferation and dispersion of cumulus cells.
|
1 | P36898 (/IMP) |
Ovarian cumulus expansion GO:0001550
Increase in size of the cumulus surrounding the oocyte including change in morphology due to proliferation and dispersion of cumulus cells.
|
1 | O00238 (/ISS) |
Blood vessel development GO:0001568
The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
|
1 | P37173 (/TAS) |
Branching involved in blood vessel morphogenesis GO:0001569
The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
|
1 | Q90ZK6 (/ISA) |
Branching involved in blood vessel morphogenesis GO:0001569
The process of coordinated growth and sprouting of blood vessels giving rise to the organized vascular system.
|
1 | P37173 (/ISS) |
Vasculogenesis GO:0001570
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
|
1 | P38438 (/IEP) |
Vasculogenesis GO:0001570
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
|
1 | Q62312 (/IMP) |
Vasculogenesis GO:0001570
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
|
1 | P37173 (/ISS) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
1 | Q90999 (/IEP) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
1 | P36898 (/IMP) |
Urogenital system development GO:0001655
The process whose specific outcome is the progression of the urogenital system over time, from its formation to the mature structure.
|
1 | P80201 (/IMP) |
Urogenital system development GO:0001655
The process whose specific outcome is the progression of the urogenital system over time, from its formation to the mature structure.
|
1 | P37172 (/ISO) |
Urogenital system development GO:0001655
The process whose specific outcome is the progression of the urogenital system over time, from its formation to the mature structure.
|
1 | Q28041 (/ISS) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | Q90999 (/ISM) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P38438 (/TAS) |
Gastrulation with mouth forming second GO:0001702
A gastrulation process in which the initial invagination becomes the anus and the mouth forms second.
|
1 | P37172 (/IMP) |
Gastrulation with mouth forming second GO:0001702
A gastrulation process in which the initial invagination becomes the anus and the mouth forms second.
|
1 | Q90ZK6 (/ISA) |
Mesoderm formation GO:0001707
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
1 | Q90ZK6 (/ISA) |
Mesoderm formation GO:0001707
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
1 | Q13873 (/ISS) |
Neural crest cell migration GO:0001755
The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo.
|
1 | Q90ZK6 (/ISA) |
Neural crest cell migration GO:0001755
The characteristic movement of cells from the dorsal ridge of the neural tube to a variety of locations in a vertebrate embryo.
|
1 | Q28041 (/ISS) |
Somitogenesis GO:0001756
The formation of mesodermal clusters that are arranged segmentally along the anterior posterior axis of an embryo.
|
1 | P36895 (/IMP) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
1 | Q90999 (/IMP) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
1 | P27040 (/IMP) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
1 | Q06900 (/ISA) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
1 | P36897 (/ISS) |
Blastocyst development GO:0001824
The process whose specific outcome is the progression of the blastocyst over time, from its formation to the mature structure. The mammalian blastocyst is a hollow ball of cells containing two cell types, the inner cell mass and the trophectoderm.
|
1 | Q64729 (/IDA) |
Trophectodermal cell proliferation GO:0001834
The proliferation of cells in the trophectoderm.
|
1 | Q8K348 (/ISO) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | P36897 (/IDA) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | Q06900 (/ISA) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | Q64729 (/ISO) |
Mullerian duct regression GO:0001880
The process in which the Mullerian ducts, primordia of the oviducts, uterus and upper vagina, undergo regression in male embryos.
|
1 | P36895 (/IMP) |
Maternal placenta development GO:0001893
Maternally driven process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
|
1 | O35607 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
1 | P27037 (/IMP) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
1 | P27038 (/ISO) |
Endothelial cell proliferation GO:0001935
The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.
|
1 | Q13873 (/IMP) |
Endothelial cell proliferation GO:0001935
The multiplication or reproduction of endothelial cells, resulting in the expansion of a cell population. Endothelial cells are thin flattened cells which line the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium.
|
1 | O35607 (/ISO) |
Regulation of endothelial cell proliferation GO:0001936
Any process that modulates the frequency, rate, or extent of endothelial cell proliferation.
|
1 | P37023 (/TAS) |
Negative regulation of endothelial cell proliferation GO:0001937
Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
|
1 | Q61288 (/IDA) |
Negative regulation of endothelial cell proliferation GO:0001937
Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
|
1 | Q64729 (/IGI) |
Negative regulation of endothelial cell proliferation GO:0001937
Any process that stops, prevents, or reduces the rate or extent of endothelial cell proliferation.
|
1 | Q06900 (/ISA) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
1 | Q61288 (/IDA) |
Positive regulation of endothelial cell proliferation GO:0001938
Any process that activates or increases the rate or extent of endothelial cell proliferation.
|
1 | O35607 (/ISO) |
Hair follicle development GO:0001942
The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
|
1 | Q61271 (/IMP) |
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
|
1 | P37173 (/ISS) |
Blood vessel maturation GO:0001955
A developmental process, independent of morphogenetic (shape) change, that is required for a blood vessel to attain its fully functional state.
|
1 | P37023 (/TAS) |
Response to dietary excess GO:0002021
The physiological process in which dietary excess is sensed by the central nervous system, resulting in a reduction in food intake and increased energy expenditure.
|
1 | Q8K348 (/IMP) |
Blood vessel endothelial cell proliferation involved in sprouting angiogenesis GO:0002043
The multiplication or reproduction of blood vessel endothelial cells, resulting in the expansion of a cell population contributing to sprouting angiogenesis.
|
1 | P37023 (/TAS) |
Positive regulation of mesenchymal cell proliferation GO:0002053
The process of activating or increasing the rate or extent of mesenchymal cell proliferation. Mesenchymal cells are loosely organized embryonic cells.
|
1 | P37173 (/ISS) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
1 | P36895 (/IDA) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
1 | P36898 (/IGI) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
1 | P36898 (/IMP) |
Chondrocyte development GO:0002063
The process whose specific outcome is the progression of a chondrocyte over time, from its commitment to its mature state. Chondrocyte development does not include the steps involved in committing a chondroblast to a chondrocyte fate.
|
1 | O35607 (/ISO) |
Lens development in camera-type eye GO:0002088
The process whose specific outcome is the progression of the lens over time, from its formation to the mature structure. The lens is a transparent structure in the eye through which light is focused onto the retina. An example of this process is found in Mus musculus.
|
1 | Q06900 (/ISA) |
Acute inflammatory response GO:0002526
Inflammation which comprises a rapid, short-lived, relatively uniform response to acute injury or antigenic challenge and is characterized by accumulations of fluid, plasma proteins, and granulocytic leukocytes. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
|
1 | P37172 (/IEP) |
Acute inflammatory response GO:0002526
Inflammation which comprises a rapid, short-lived, relatively uniform response to acute injury or antigenic challenge and is characterized by accumulations of fluid, plasma proteins, and granulocytic leukocytes. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
|
1 | Q90ZK6 (/ISA) |
Positive regulation of tolerance induction to self antigen GO:0002651
Any process that activates or increases the frequency, rate, or extent of tolerance induction to self antigen.
|
1 | Q62312 (/IMP) |
Positive regulation of tolerance induction to self antigen GO:0002651
Any process that activates or increases the frequency, rate, or extent of tolerance induction to self antigen.
|
1 | P37173 (/ISS) |
Positive regulation of B cell tolerance induction GO:0002663
Any process that activates or increases the frequency, rate, or extent of B cell tolerance induction.
|
1 | Q62312 (/IMP) |
Positive regulation of B cell tolerance induction GO:0002663
Any process that activates or increases the frequency, rate, or extent of B cell tolerance induction.
|
1 | P37173 (/ISS) |
Positive regulation of T cell tolerance induction GO:0002666
Any process that activates or increases the frequency, rate, or extent of T cell tolerance induction.
|
1 | Q62312 (/IMP) |
Positive regulation of T cell tolerance induction GO:0002666
Any process that activates or increases the frequency, rate, or extent of T cell tolerance induction.
|
1 | P37173 (/ISS) |
Heart morphogenesis GO:0003007
The developmental process in which the heart is generated and organized. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P36895 (/IMP) |
Negative regulation of systemic arterial blood pressure GO:0003085
The process that reduces the force with which blood travels through the systemic arterial circulatory system.
|
1 | Q13873 (/IMP) |
Negative regulation of systemic arterial blood pressure GO:0003085
The process that reduces the force with which blood travels through the systemic arterial circulatory system.
|
1 | O35607 (/ISO) |
Embryonic heart tube morphogenesis GO:0003143
The process in which the anatomical structures of the embryonic heart tube are generated and organized. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
|
1 | Q90ZK6 (/ISA) |
Embryonic heart tube morphogenesis GO:0003143
The process in which the anatomical structures of the embryonic heart tube are generated and organized. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
|
1 | P37172 (/ISO) |
Membranous septum morphogenesis GO:0003149
The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum.
|
1 | Q62312 (/IMP) |
Membranous septum morphogenesis GO:0003149
The process in which the membranous septum is generated and organized. The membranous septum is the upper part of ventricular septum.
|
1 | P37173 (/ISS) |
Cardiac conduction system development GO:0003161
The process whose specific outcome is the progression of the cardiac conduction system over time, from its formation to the mature structure. The cardiac conduction system consists of specialized cardiomyocytes that regulate the frequency of heart beat.
|
1 | P36895 (/IMP) |
Cardiac conduction system development GO:0003161
The process whose specific outcome is the progression of the cardiac conduction system over time, from its formation to the mature structure. The cardiac conduction system consists of specialized cardiomyocytes that regulate the frequency of heart beat.
|
1 | P36894 (/ISS) |
Mitral valve morphogenesis GO:0003183
The process in which the structure of the mitral valve is generated and organized.
|
1 | Q90ZK6 (/ISA) |
Mitral valve morphogenesis GO:0003183
The process in which the structure of the mitral valve is generated and organized.
|
1 | P37172 (/ISO) |
Endocardial cushion development GO:0003197
The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
1 | O35607 (/IMP) |
Endocardial cushion development GO:0003197
The progression of a cardiac cushion over time, from its initial formation to the mature structure. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
1 | Q13873 (/ISS) |
Cardiac left ventricle morphogenesis GO:0003214
The process in which the left cardiac ventricle is generated and organized.
|
1 | Q62312 (/IMP) |
Cardiac left ventricle morphogenesis GO:0003214
The process in which the left cardiac ventricle is generated and organized.
|
1 | P37173 (/ISS) |
Cardiac right ventricle morphogenesis GO:0003215
The process in which the right cardiac ventricle is generated and organized.
|
1 | P36895 (/IMP) |
Cardiac right ventricle morphogenesis GO:0003215
The process in which the right cardiac ventricle is generated and organized.
|
1 | P36894 (/ISS) |
Negative regulation of cell proliferation involved in heart valve morphogenesis GO:0003252
Any process that decreases the rate, frequency or extent of cell proliferation that contributes to the shaping of a heart valve.
|
1 | O35607 (/IMP) |
Negative regulation of cell proliferation involved in heart valve morphogenesis GO:0003252
Any process that decreases the rate, frequency or extent of cell proliferation that contributes to the shaping of a heart valve.
|
1 | Q13873 (/ISS) |
Endocardial cushion formation GO:0003272
The developmental process pertaining to the initial formation of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
1 | P36895 (/IMP) |
Endocardial cushion formation GO:0003272
The developmental process pertaining to the initial formation of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
1 | P36894 (/ISS) |
Atrial septum primum morphogenesis GO:0003289
The process in which anatomical structure of an atrial septum primum is generated and organized.
|
1 | Q90ZK6 (/ISA) |
Atrial septum primum morphogenesis GO:0003289
The process in which anatomical structure of an atrial septum primum is generated and organized.
|
1 | P37172 (/ISO) |
Atrial septum primum morphogenesis GO:0003289
The process in which anatomical structure of an atrial septum primum is generated and organized.
|
1 | Q04771 (/ISS) |
Growth plate cartilage development GO:0003417
The process whose specific outcome is the progression of the cartilage that will provide a scaffold for mineralization of endochondral bones as they elongate or grow.
|
1 | Q62312 (/IGI) |
Growth plate cartilage chondrocyte growth GO:0003430
The growth of a growth plate cartilage chondrocyte, where growth contributes to the progression of the chondrocyte over time from one condition to another.
|
1 | Q62312 (/IMP) |
Regulation of DNA replication GO:0006275
Any process that modulates the frequency, rate or extent of DNA replication.
|
1 | P37023 (/TAS) |
Regulation of transcription, DNA-templated GO:0006355
Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
|
1 | Q06900 (/ISA) |
Transcription from RNA polymerase II promoter GO:0006366
The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
|
1 | Q13873 (/IMP) |
Transcription from RNA polymerase II promoter GO:0006366
The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).
|
1 | O35607 (/ISO) |
Estrogen biosynthetic process GO:0006703
The chemical reactions and pathways resulting in the formation of estrogens, C18 steroid hormones that can stimulate the development of female sexual characteristics. Also found in plants.
|
1 | P36898 (/NAS) |
Receptor-mediated endocytosis GO:0006898
An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
|
1 | P38438 (/IDA) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
1 | P37173 (/IDA) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
1 | Q90999 (/ISA) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
1 | Q62312 (/ISO) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
1 | P36898 (/IEP) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
1 | P36894 (/IMP) |
Immune response GO:0006955
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
|
1 | P36895 (/ISO) |
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
|
1 | P36897 (/TAS) |
Negative regulation of cell adhesion GO:0007162
Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.
|
1 | P37023 (/IMP) |
Negative regulation of cell adhesion GO:0007162
Any process that stops, prevents, or reduces the frequency, rate or extent of cell adhesion.
|
1 | Q61288 (/ISO) |
Signal transduction GO:0007165
The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
|
1 | Q06900 (/ISA) |
Cell surface receptor signaling pathway GO:0007166
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q61271 (/TAS) |
Transmembrane receptor protein serine/threonine kinase signaling pathway GO:0007178
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses serine/threonine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q13873 (/IDA) |
Transmembrane receptor protein serine/threonine kinase signaling pathway GO:0007178
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses serine/threonine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P36898 (/IGI) |
Transmembrane receptor protein serine/threonine kinase signaling pathway GO:0007178
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses serine/threonine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | O35607 (/ISO) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q90999 (/ISM) |
Transforming growth factor beta receptor complex assembly GO:0007181
The aggregation, arrangement and bonding together of a ligand-bound type II transforming growth factor beta (TGF-beta) receptor dimer with a type I TGF-beta receptor dimer, following ligand binding, to form a heterotetrameric TGF-beta receptor complex.
|
1 | P70539 (/IDA) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
1 | P38438 (/IDA) |
Notch signaling pathway GO:0007219
A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q62312 (/IDA) |
Smoothened signaling pathway GO:0007224
A series of molecular signals generated as a consequence of activation of the transmembrane protein Smoothened.
|
1 | Q62312 (/IMP) |
Germ cell development GO:0007281
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
|
1 | P37172 (/IMP) |
Germ cell development GO:0007281
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
|
1 | Q90ZK6 (/ISA) |
Germ cell development GO:0007281
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
|
1 | Q28041 (/ISS) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
1 | P27038 (/IGI) |
Determination of left/right symmetry GO:0007368
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
|
1 | Q90ZK6 (/ISA) |
Determination of left/right symmetry GO:0007368
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
|
1 | Q28041 (/ISS) |
Gastrulation GO:0007369
A complex and coordinated series of cellular movements that occurs at the end of cleavage during embryonic development of most animals. The details of gastrulation vary from species to species, but usually result in the formation of the three primary germ layers, ectoderm, mesoderm and endoderm.
|
1 | Q90ZK6 (/ISA) |
Pattern specification process GO:0007389
Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate.
|
1 | P27040 (/IGI) |
Pattern specification process GO:0007389
Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate.
|
1 | P36895 (/IMP) |
Ectoderm development GO:0007398
The process whose specific outcome is the progression of the ectoderm over time, from its formation to the mature structure. In animal embryos, the ectoderm is the outer germ layer of the embryo, formed during gastrulation.
|
1 | P36895 (/IMP) |
Nervous system development GO:0007399
The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state.
|
1 | P36895 (/IMP) |
Central nervous system development GO:0007417
The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.
|
1 | P80202 (/IEP) |
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
1 | F1LQC5 (/IEP) |
Brain development GO:0007420
The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.).
|
1 | P37173 (/ISS) |
Endoderm development GO:0007492
The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
|
1 | P36895 (/IMP) |
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
1 | P27040 (/IGI) |
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
1 | Q90ZK6 (/ISA) |
Mesoderm development GO:0007498
The process whose specific outcome is the progression of the mesoderm over time, from its formation to the mature structure. The mesoderm is the middle germ layer that develops into muscle, bone, cartilage, blood and connective tissue.
|
1 | Q61271 (/ISO) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | Q90999 (/IEP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
1 | P27040 (/IGI) |
Response to nutrient GO:0007584
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
|
1 | P38438 (/IEP) |
Blood circulation GO:0008015
The flow of blood through the body of an animal, enabling the transport of nutrients to the tissues and the removal of waste products.
|
1 | P37023 (/IMP) |
Blood circulation GO:0008015
The flow of blood through the body of an animal, enabling the transport of nutrients to the tissues and the removal of waste products.
|
1 | Q61288 (/ISO) |
Regulation of blood pressure GO:0008217
Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
|
1 | P37023 (/IMP) |
Regulation of blood pressure GO:0008217
Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
|
1 | Q61288 (/ISO) |
Positive regulation of cell proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
1 | Q06900 (/ISA) |
Positive regulation of cell proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
1 | Q64729 (/ISO) |
Positive regulation of cell proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
1 | P37173 (/TAS) |
Negative regulation of cell proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | P38438 (/IGI) |
Negative regulation of cell proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
1 | Q61288 (/ISO) |
Germ cell migration GO:0008354
The orderly movement of a cell specialized to produce haploid gametes through the embryo from its site of production to the place where the gonads will form.
|
1 | Q06900 (/ISA) |
Germ cell migration GO:0008354
The orderly movement of a cell specialized to produce haploid gametes through the embryo from its site of production to the place where the gonads will form.
|
1 | P36897 (/ISS) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
1 | Q06900 (/ISA) |
Cellular response to starvation GO:0009267
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
|
1 | Q13873 (/IEP) |
Response to mechanical stimulus GO:0009612
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | P38438 (/IEP) |
Response to toxic substance GO:0009636
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxic stimulus.
|
1 | P80204 (/IEP) |
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
1 | P27040 (/IGI) |
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
1 | Q8K348 (/IMP) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
1 | P27040 (/IGI) |
Post-embryonic development GO:0009791
The process whose specific outcome is the progression of the organism over time, from the completion of embryonic development to the mature structure. See embryonic development.
|
1 | Q06900 (/ISA) |
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
1 | P38438 (/IMP) |
Dorsal/ventral axis specification GO:0009950
The establishment, maintenance and elaboration of the dorsal/ventral axis. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
1 | P36895 (/IMP) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
1 | Q06900 (/ISA) |
Anterior/posterior pattern specification GO:0009952
The regionalization process in which specific areas of cell differentiation are determined along the anterior-posterior axis. The anterior-posterior axis is defined by a line that runs from the head or mouth of an organism to the tail or opposite end of the organism.
|
1 | P27040 (/ISO) |
Negative regulation of signal transduction GO:0009968
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction.
|
1 | Q04771 (/IMP) |
Negative regulation of signal transduction GO:0009968
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction.
|
1 | Q90ZK6 (/ISA) |
Negative regulation of signal transduction GO:0009968
Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction.
|
1 | P37172 (/ISO) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | Q06900 (/ISA) |
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
1 | Q13873 (/IMP) |
Positive regulation of endothelial cell migration GO:0010595
Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
1 | O35607 (/ISO) |
Negative regulation of endothelial cell migration GO:0010596
Any process that decreases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
1 | P37023 (/IDA) |
Negative regulation of endothelial cell migration GO:0010596
Any process that decreases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
1 | Q61288 (/ISO) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | Q90999 (/TAS) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
1 | P37023 (/ISS) |
Positive regulation of epithelial cell migration GO:0010634
Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
|
1 | Q13873 (/IDA) |
Positive regulation of epithelial cell migration GO:0010634
Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
|
1 | Q62312 (/IMP) |
Positive regulation of epithelial cell migration GO:0010634
Any process that activates or increases the frequency, rate or extent of epithelial cell migration.
|
1 | O35607 (/ISO) |
Positive regulation of alkaline phosphatase activity GO:0010694
Any process that increases the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.
|
1 | Q90ZK6 (/IMP) |
Regulation of epithelial to mesenchymal transition GO:0010717
Any process that modulates the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | Q06900 (/IMP) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | P37173 (/IDA) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | Q64729 (/IGI) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | Q90999 (/ISA) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | Q90999 (/ISM) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | Q62312 (/ISO) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
1 | Q04771 (/ISS) |
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
1 | Q90999 (/ISM) |
Neural crest cell development GO:0014032
The process aimed at the progression of a neural crest cell over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell.
|
1 | P36895 (/IMP) |
Negative regulation of smooth muscle cell migration GO:0014912
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration.
|
1 | P36894 (/IMP) |
Negative regulation of smooth muscle cell migration GO:0014912
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration.
|
1 | P36895 (/ISO) |
Regulation of lung blood pressure GO:0014916
The process that modulates the force with which blood travels through the lungs. The process is controlled by a balance of processes that increase pressure and decrease pressure.
|
1 | O35607 (/ISO) |
Regulation of lung blood pressure GO:0014916
The process that modulates the force with which blood travels through the lungs. The process is controlled by a balance of processes that increase pressure and decrease pressure.
|
1 | Q13873 (/ISS) |
Detection of bacterium GO:0016045
The series of events in which a stimulus from a bacterium is received and converted into a molecular signal.
|
1 | P20792 (/IMP) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
1 | Q90999 (/TAS) |
Protein deubiquitination GO:0016579
The removal of one or more ubiquitin groups from a protein.
|
1 | P36897 (/TAS) |
Peptidyl-serine phosphorylation GO:0018105
The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine.
|
1 | Q06900 (/ISA) |
Stem cell population maintenance GO:0019827
The process by which an organism or tissue maintains a population of stem cells of a single type. This can be achieved by a number of mechanisms: stem cell asymmetric division maintains stem cell numbers; stem cell symmetric division increases them; maintenance of a stem cell niche maintains the conditions for commitment to the stem cell fate for some types of stem cell; stem cells may arise de novo from other cell types.
|
1 | P36895 (/IMP) |
Lipid storage GO:0019915
The accumulation and maintenance in cells or tissues of lipids, compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. Lipid reserves can be accumulated during early developmental stages for mobilization and utilization at later stages of development.
|
1 | Q8K348 (/IMP) |
Sexual reproduction GO:0019953
A reproduction process that creates a new organism by combining the genetic material of two organisms. It occurs both in eukaryotes and prokaryotes: in multicellular eukaryotic organisms, an individual is created anew; in prokaryotes, the initial cell has additional or transformed genetic material. In a process called genetic recombination, genetic material (DNA) originating from two different individuals (parents) join up so that homologous sequences are aligned with each other, and this is followed by exchange of genetic information. After the new recombinant chromosome is formed, it is passed on to progeny.
|
1 | P38445 (/NAS) |
Cerebellum development GO:0021549
The process whose specific outcome is the progression of the cerebellum over time, from its formation to the mature structure. The cerebellum is the portion of the brain in the back of the head between the cerebrum and the pons. In mice, the cerebellum controls balance for walking and standing, modulates the force and range of movement and is involved in the learning of motor skills.
|
1 | P70539 (/IEP) |
Hippocampus development GO:0021766
The progression of the hippocampus over time from its initial formation until its mature state.
|
1 | P70539 (/IEP) |
Pituitary gland development GO:0021983
The progression of the pituitary gland over time from its initial formation until its mature state. The pituitary gland is an endocrine gland that secretes hormones that regulate many other glands.
|
1 | P36895 (/IMP) |
Neural plate mediolateral regionalization GO:0021998
The process that regulates the coordinated growth and differentiation that establishes the non-random mediolateral spatial arrangement of the neural plate.
|
1 | P36895 (/IMP) |
Regulation of cell morphogenesis GO:0022604
Any process that modulates the frequency, rate or extent of cell morphogenesis. Cell morphogenesis is the developmental process in which the shape of a cell is generated and organized.
|
1 | P50488 (/IMP) |
Insulin secretion GO:0030073
The regulated release of proinsulin from secretory granules (B granules) in the B cells of the pancreas; accompanied by cleavage of proinsulin to form mature insulin.
|
1 | P27040 (/IGI) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
1 | P36898 (/IMP) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
1 | Q8K348 (/ISO) |
Cell differentiation GO:0030154
The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
|
1 | Q8K348 (/ISS) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
1 | Q64729 (/IMP) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
1 | Q06900 (/ISA) |
Collagen fibril organization GO:0030199
Any process that determines the size and arrangement of collagen fibrils within an extracellular matrix.
|
1 | P36897 (/ISS) |
Apoptotic nuclear changes GO:0030262
Alterations undergone by nuclei at the molecular and morphological level as part of the execution phase of apoptosis.
|
1 | Q8NER5 (/IDA) |
Apoptotic nuclear changes GO:0030262
Alterations undergone by nuclei at the molecular and morphological level as part of the execution phase of apoptosis.
|
1 | Q8K348 (/ISO) |
Regulation of ossification GO:0030278
Any process that modulates the frequency, rate or extent of bone formation.
|
1 | Q04771 (/IMP) |
Regulation of ossification GO:0030278
Any process that modulates the frequency, rate or extent of bone formation.
|
1 | Q90ZK6 (/ISA) |
Regulation of ossification GO:0030278
Any process that modulates the frequency, rate or extent of bone formation.
|
1 | P37172 (/ISO) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | P36897 (/IDA) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | Q06900 (/ISA) |
Positive regulation of cell growth GO:0030307
Any process that activates or increases the frequency, rate, extent or direction of cell growth.
|
1 | Q64729 (/ISO) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
1 | P27040 (/IGI) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
1 | P36897 (/IDA) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
1 | Q04771 (/IGI) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
1 | Q90999 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
1 | Q90999 (/TAS) |
Negative regulation of cell migration GO:0030336
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
|
1 | P37023 (/IMP) |
Negative regulation of cell migration GO:0030336
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration.
|
1 | Q61288 (/ISO) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
1 | Q90ZK6 (/ISA) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q90ZK6 (/ISA) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | O00238 (/NAS) |
Larval feeding behavior GO:0030536
Feeding behavior in a larval (immature) organism.
|
1 | P20792 (/IGI) |
Midbrain development GO:0030901
The process whose specific outcome is the progression of the midbrain over time, from its formation to the mature structure. The midbrain is the middle division of the three primary divisions of the developing chordate brain or the corresponding part of the adult brain (in vertebrates, includes a ventral part containing the cerebral peduncles and a dorsal tectum containing the corpora quadrigemina and that surrounds the aqueduct of Sylvius connecting the third and fourth ventricles).
|
1 | P70539 (/IEP) |
Pancreas development GO:0031016
The process whose specific outcome is the progression of the pancreas over time, from its formation to the mature structure. The pancreas is an endoderm derived structure that produces precursors of digestive enzymes and blood glucose regulating enzymes.
|
1 | P27040 (/IGI) |
Retinal ganglion cell axon guidance GO:0031290
The process in which the migration of an axon growth cone of a retinal ganglion cell (RGC) is directed to its target in the brain in response to a combination of attractive and repulsive cues.
|
1 | P36898 (/IMP) |
Regulation of protein ubiquitination GO:0031396
Any process that modulates the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
1 | P36897 (/IDA) |
Regulation of protein ubiquitination GO:0031396
Any process that modulates the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
1 | Q06900 (/ISA) |
Regulation of protein ubiquitination GO:0031396
Any process that modulates the frequency, rate or extent of the addition of ubiquitin groups to a protein.
|
1 | Q64729 (/ISO) |
Activation of protein kinase activity GO:0032147
Any process that initiates the activity of an inactive protein kinase.
|
1 | P37173 (/ISS) |
Negative regulation of chondrocyte differentiation GO:0032331
Any process that stops, prevents, or reduces the frequency, rate or extent of chondrocyte differentiation.
|
1 | Q64729 (/IMP) |
Negative regulation of chondrocyte differentiation GO:0032331
Any process that stops, prevents, or reduces the frequency, rate or extent of chondrocyte differentiation.
|
1 | Q06900 (/ISA) |
Negative regulation of chondrocyte differentiation GO:0032331
Any process that stops, prevents, or reduces the frequency, rate or extent of chondrocyte differentiation.
|
1 | P36897 (/ISS) |
Positive regulation of chondrocyte differentiation GO:0032332
Any process that activates or increases the frequency, rate or extent of chondrocyte differentiation.
|
1 | Q05438 (/IDA) |
Positive regulation of chondrocyte differentiation GO:0032332
Any process that activates or increases the frequency, rate or extent of chondrocyte differentiation.
|
1 | P37023 (/TAS) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
1 | Q90999 (/ISM) |
Response to insulin GO:0032868
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
1 | Q8K348 (/IMP) |
Activin receptor signaling pathway GO:0032924
A series of molecular signals initiated by the binding of an extracellular ligand to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q90ZK6 (/ISA) |
Negative regulation of activin receptor signaling pathway GO:0032926
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
1 | Q04771 (/IMP) |
Negative regulation of activin receptor signaling pathway GO:0032926
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
1 | Q90ZK6 (/ISA) |
Negative regulation of activin receptor signaling pathway GO:0032926
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of any activin receptor signaling pathway.
|
1 | P37172 (/ISO) |
Response to lipid GO:0033993
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus.
|
1 | P70539 (/IEP) |
Response to prostaglandin E GO:0034695
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
|
1 | P80204 (/IEP) |
Limb morphogenesis GO:0035108
The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping.
|
1 | O00238 (/IMP) |
Limb morphogenesis GO:0035108
The process in which the anatomical structures of a limb are generated and organized. A limb is a paired appendage of a tetrapod used for locomotion or grasping.
|
1 | P36898 (/ISO) |
Hindlimb morphogenesis GO:0035137
The process in which the anatomical structures of the hindlimb are generated and organized.
|
1 | P36895 (/IMP) |
Embryonic hemopoiesis GO:0035162
The stages of blood cell formation that take place within the embryo.
|
1 | P37173 (/ISS) |
Organ growth GO:0035265
The increase in size or mass of an organ. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that function together as to perform a specific function.
|
1 | P27040 (/IGI) |
Wound healing, spreading of epidermal cells GO:0035313
The migration of an epidermal cell along or through a wound gap that contributes to the reestablishment of a continuous epidermis.
|
1 | P37023 (/IMP) |
Wound healing, spreading of epidermal cells GO:0035313
The migration of an epidermal cell along or through a wound gap that contributes to the reestablishment of a continuous epidermis.
|
1 | Q61288 (/ISO) |
Nodal signaling pathway GO:0038092
A series of molecular signals initiated by the binding of a nodal protein to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | P36896 (/IGI) |
Nodal signaling pathway GO:0038092
A series of molecular signals initiated by the binding of a nodal protein to an activin receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q8NER5 (/IMP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
1 | P38438 (/IEP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
1 | P36897 (/TAS) |
Endothelial cell activation GO:0042118
The change in morphology and behavior of an endothelial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.
|
1 | Q61288 (/TAS) |
Regulation of cell proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
1 | O35607 (/ISO) |
Regulation of cell proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
1 | P37173 (/ISS) |
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
1 | P27040 (/IGI) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P37173 (/IDA) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P70539 (/IEP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | Q90999 (/ISA) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | Q62312 (/ISO) |
Ovulation cycle GO:0042698
The type of sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years.
|
1 | P36898 (/IMP) |
Ovulation cycle GO:0042698
The type of sexual cycle seen in females, often with physiologic changes in the endometrium that recur at regular intervals during the reproductive years.
|
1 | O00238 (/ISS) |
Sperm ejaculation GO:0042713
The expulsion of seminal fluid, thick white fluid containing spermatozoa, from the male genital tract.
|
1 | P27038 (/IMP) |
Embryonic digit morphogenesis GO:0042733
The process, occurring in the embryo, by which the anatomical structures of the digit are generated and organized. A digit is one of the terminal divisions of an appendage, such as a finger or toe.
|
1 | P36895 (/IGI) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
1 | P70539 (/IDA) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
1 | Q8K348 (/ISS) |
Camera-type eye development GO:0043010
The process whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
|
1 | P36898 (/IGI) |
Myeloid dendritic cell differentiation GO:0043011
The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
|
1 | Q62312 (/IMP) |
Myeloid dendritic cell differentiation GO:0043011
The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
|
1 | P37173 (/ISS) |
Regulation of pharyngeal pumping GO:0043051
Any process that modulates the contraction and relaxation movements of the pharyngeal muscle that mediates feeding in nematodes.
|
1 | P20792 (/IMP) |
Extracellular structure organization GO:0043062
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of structures in the space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane, and also covers the host cell environment outside an intracellular parasite.
|
1 | P36897 (/TAS) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
1 | Q8K348 (/ISO) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
1 | Q06900 (/ISA) |
Penile erection GO:0043084
The hardening, enlarging and rising of the penis which often occurs in the sexually aroused male and enables sexual intercourse. Achieved by increased inflow of blood into the vessels of erectile tissue, and decreased outflow.
|
1 | P27038 (/IMP) |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
1 | Q8NER5 (/IMP) |
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
1 | Q8K348 (/ISO) |
Regulation of protein binding GO:0043393
Any process that modulates the frequency, rate or extent of protein binding.
|
1 | Q64729 (/IMP) |
Regulation of protein binding GO:0043393
Any process that modulates the frequency, rate or extent of protein binding.
|
1 | Q06900 (/ISA) |
Positive regulation of skeletal muscle tissue regeneration GO:0043415
Any process that activates or increase the rate of skeletal muscle regeneration.
|
1 | P38438 (/IEP) |
Regulation of blood vessel endothelial cell migration GO:0043535
Any process that modulates the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
1 | P37023 (/TAS) |
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
1 | P37023 (/IMP) |
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
1 | Q61288 (/ISO) |
Endothelial cell migration GO:0043542
The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
1 | Q64729 (/IMP) |
Endothelial cell migration GO:0043542
The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium.
|
1 | Q06900 (/ISA) |
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
|
1 | P80204 (/IDA) |
Response to estrogen GO:0043627
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
|
1 | P38438 (/IEP) |
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
|
1 | Q90999 (/ISM) |
Positive regulation of cell differentiation GO:0045597
Any process that activates or increases the frequency, rate or extent of cell differentiation.
|
1 | O00238 (/IMP) |
Positive regulation of cell differentiation GO:0045597
Any process that activates or increases the frequency, rate or extent of cell differentiation.
|
1 | P36898 (/ISO) |
Negative regulation of endothelial cell differentiation GO:0045602
Any process that stops, prevents, or reduces the frequency, rate or extent of endothelial cell differentiation.
|
1 | Q61288 (/IDA) |
Negative regulation of endothelial cell differentiation GO:0045602
Any process that stops, prevents, or reduces the frequency, rate or extent of endothelial cell differentiation.
|
1 | P80204 (/IMP) |
Positive regulation of endothelial cell differentiation GO:0045603
Any process that activates or increases the frequency, rate or extent of endothelial cell differentiation.
|
1 | Q61288 (/IDA) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
1 | Q90ZK6 (/ISA) |
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of bone formation.
|
1 | O35607 (/IMP) |
Positive regulation of ossification GO:0045778
Any process that activates or increases the frequency, rate or extent of bone formation.
|
1 | Q13873 (/ISS) |
Negative regulation of vasoconstriction GO:0045906
Any process that stops, prevents, or reduces the frequency, rate or extent of vasoconstriction.
|
1 | O35607 (/IMP) |
Negative regulation of vasoconstriction GO:0045906
Any process that stops, prevents, or reduces the frequency, rate or extent of vasoconstriction.
|
1 | Q13873 (/ISS) |
Positive regulation of transcription from RNA polymerase II promoter GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
1 | Q90ZK6 (/ISA) |
Development of primary female sexual characteristics GO:0046545
The process whose specific outcome is the progression of the primary female sexual characteristics over time, from their formation to the mature structure. The primary female sexual characteristics are the ovaries, and they develop in response to sex hormone secretion.
|
1 | P80202 (/IEP) |
Negative regulation of insulin secretion GO:0046676
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin.
|
1 | Q8K348 (/IMP) |
Protein autophosphorylation GO:0046777
The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
|
1 | P36896 (/IDA) |
Protein autophosphorylation GO:0046777
The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
|
1 | P80204 (/IMP) |
Protein autophosphorylation GO:0046777
The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
|
1 | Q61271 (/ISO) |
Positive regulation of follicle-stimulating hormone secretion GO:0046881
Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone.
|
1 | P38444 (/IMP) |
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | O35607 (/IMP) |
Vascular endothelial growth factor receptor signaling pathway GO:0048010
Any series of molecular signals initiated by the binding of an extracellular ligand to a vascular endothelial growth factor receptor (VEGFR) located on the surface of the receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
1 | Q13873 (/ISS) |
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
|
1 | O35607 (/IMP) |
Lung alveolus development GO:0048286
The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.
|
1 | Q13873 (/ISS) |
Paraxial mesoderm development GO:0048339
The process whose specific outcome is the progression of the paraxial mesoderm over time, from its formation to the mature structure. The paraxial mesoderm is the mesoderm located bilaterally adjacent to the notochord and neural tube.
|
1 | P36895 (/IGI) |
Paraxial mesoderm development GO:0048339
The process whose specific outcome is the progression of the paraxial mesoderm over time, from its formation to the mature structure. The paraxial mesoderm is the mesoderm located bilaterally adjacent to the notochord and neural tube.
|
1 | P36895 (/IMP) |
Paraxial mesoderm structural organization GO:0048352
The process that contributes to the act of creating the structural organization of the paraxial mesoderm. This process pertains to the physical shaping of a rudimentary structure.
|
1 | P36895 (/IMP) |
Regulation of lateral mesodermal cell fate specification GO:0048378
Any process that modulates the frequency, rate or extent of lateral mesoderm cell fate specification.
|
1 | P36895 (/IGI) |
Mesendoderm development GO:0048382
The process whose specific outcome is the progression of the mesendoderm over time, from its formation to the mature structure. In animal embryos, mesendoderm development gives rise to both mesoderm and endoderm tissues.
|
1 | P36895 (/IMP) |
Thymus development GO:0048538
The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
|
1 | Q64729 (/IMP) |
Thymus development GO:0048538
The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
|
1 | Q06900 (/ISA) |
Thymus development GO:0048538
The process whose specific outcome is the progression of the thymus over time, from its formation to the mature structure. The thymus is a symmetric bi-lobed organ involved primarily in the differentiation of immature to mature T cells, with unique vascular, nervous, epithelial, and lymphoid cell components.
|
1 | P36897 (/ISS) |
Response to steroid hormone GO:0048545
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
|
1 | P38438 (/IEP) |
Embryonic organ development GO:0048568
Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
1 | Q90999 (/IEP) |
Embryonic organ development GO:0048568
Development, taking place during the embryonic phase, of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
1 | P36895 (/IMP) |
Developmental growth GO:0048589
The increase in size or mass of an entire organism, a part of an organism or a cell, where the increase in size or mass has the specific outcome of the progression of the organism over time from one condition to another.
|
1 | P36895 (/IMP) |
Embryonic morphogenesis GO:0048598
The process in which anatomical structures are generated and organized during the embryonic phase. The embryonic phase begins with zygote formation. The end of the embryonic phase is organism-specific. For example, it would be at birth for mammals, larval hatching for insects and seed dormancy in plants.
|
1 | P36895 (/IMP) |
Embryonic foregut morphogenesis GO:0048617
The process in which the anatomical structures of the foregut are generated and organized, during the embryonic phase.
|
1 | P27040 (/IMP) |
Regulation of skeletal muscle tissue development GO:0048641
Any process that modulates the frequency, rate or extent of skeletal muscle tissue development.
|
1 | P80201 (/IEP) |
Positive regulation of smooth muscle cell proliferation GO:0048661
Any process that activates or increases the rate or extent of smooth muscle cell proliferation.
|
1 | P38438 (/IMP) |
Neuron fate commitment GO:0048663
The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
|
1 | Q64729 (/IMP) |
Neuron fate commitment GO:0048663
The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
|
1 | Q06900 (/ISA) |
Neuron fate commitment GO:0048663
The process in which the developmental fate of a cell becomes restricted such that it will develop into a neuron.
|
1 | P36897 (/ISS) |
Embryonic cranial skeleton morphogenesis GO:0048701
The process in which the anatomical structures of the cranial skeleton are generated and organized during the embryonic phase.
|
1 | Q06900 (/ISA) |
Skeletal system morphogenesis GO:0048705
The process in which the anatomical structures of the skeleton are generated and organized.
|
1 | P27040 (/IMP) |
Skeletal system morphogenesis GO:0048705
The process in which the anatomical structures of the skeleton are generated and organized.
|
1 | Q06900 (/ISA) |
Skeletal system morphogenesis GO:0048705
The process in which the anatomical structures of the skeleton are generated and organized.
|
1 | P36897 (/ISS) |
Embryonic skeletal system development GO:0048706
The process, occurring during the embryonic phase, whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure.
|
1 | P27038 (/IMP) |
Positive regulation of axon extension involved in axon guidance GO:0048842
Any process that activates, maintains or increases the frequency, rate or extent of axon extension involved in axon guidance.
|
1 | O35607 (/IMP) |
Artery morphogenesis GO:0048844
The process in which the anatomical structures of arterial blood vessels are generated and organized. Arteries are blood vessels that transport blood from the heart to the body and its organs.
|
1 | Q06900 (/ISA) |
Artery morphogenesis GO:0048844
The process in which the anatomical structures of arterial blood vessels are generated and organized. Arteries are blood vessels that transport blood from the heart to the body and its organs.
|
1 | P36897 (/ISS) |
Cell motility GO:0048870
Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another.
|
1 | P36897 (/IMP) |
Cell motility GO:0048870
Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another.
|
1 | Q06900 (/ISA) |
Cell motility GO:0048870
Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another.
|
1 | Q64729 (/ISO) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
1 | P36895 (/IMP) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
1 | Q90999 (/ISM) |
Negative regulation of neurogenesis GO:0050768
Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the origin and formation of neurons.
|
1 | P36895 (/IMP) |
Regulation of nitric-oxide synthase activity GO:0050999
Any process that modulates the activity of the enzyme nitric-oxide synthase.
|
1 | P27038 (/IMP) |
Synaptic growth at neuromuscular junction GO:0051124
The growth of a synapse at a neuromuscular junction, the site of apposition of a motor end plate and the subneural cleft of the skeletal muscle fiber that it innervates.
|
1 | M9PE88 (/IGI) |
Positive regulation of NK T cell differentiation GO:0051138
Any process that activates or increases the frequency, rate or extent of natural killer T cell differentiation.
|
1 | Q62312 (/IMP) |
Positive regulation of NK T cell differentiation GO:0051138
Any process that activates or increases the frequency, rate or extent of natural killer T cell differentiation.
|
1 | P37173 (/ISS) |
Smooth muscle cell differentiation GO:0051145
The process in which a relatively unspecialized cell acquires specialized features of a smooth muscle cell; smooth muscle lacks transverse striations in its constituent fibers and are almost always involuntary.
|
1 | P37172 (/IMP) |
Smooth muscle cell differentiation GO:0051145
The process in which a relatively unspecialized cell acquires specialized features of a smooth muscle cell; smooth muscle lacks transverse striations in its constituent fibers and are almost always involuntary.
|
1 | Q90ZK6 (/ISA) |
Positive regulation of cellular component movement GO:0051272
Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.
|
1 | P36897 (/IMP) |
Positive regulation of cellular component movement GO:0051272
Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.
|
1 | Q06900 (/ISA) |
Positive regulation of cellular component movement GO:0051272
Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.
|
1 | Q64729 (/ISO) |
Protein heterooligomerization GO:0051291
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers that are not all identical. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
|
1 | P80203 (/IDA) |
Positive regulation of filopodium assembly GO:0051491
Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
|
1 | Q64729 (/IMP) |
Positive regulation of filopodium assembly GO:0051491
Any process that activates or increases the frequency, rate or extent of the assembly of a filopodium, a thin, stiff protrusion extended by the leading edge of a motile cell such as a crawling fibroblast or amoeba, or an axonal growth cone.
|
1 | Q06900 (/ISA) |
Positive regulation of stress fiber assembly GO:0051496
Any process that activates or increases the frequency, rate or extent of the assembly of a stress fiber, a bundle of microfilaments and other proteins found in fibroblasts.
|
1 | Q64729 (/IGI) |
Response to electrical stimulus GO:0051602
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus.
|
1 | P80204 (/IEP) |
Negative regulation of focal adhesion assembly GO:0051895
Any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
|
1 | P37023 (/IMP) |
Negative regulation of focal adhesion assembly GO:0051895
Any process that stops, prevents, or reduces the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.
|
1 | Q61288 (/ISO) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
1 | P36897 (/IDA) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
1 | Q06900 (/ISA) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
1 | Q64729 (/ISO) |
Sertoli cell proliferation GO:0060011
The multiplication or reproduction of Sertoli cells, resulting in the expansion of the Sertoli cell population. A Sertoli cell is a supporting cell projecting inward from the basement membrane of seminiferous tubules.
|
1 | P27038 (/IMP) |
Parathyroid gland development GO:0060017
The process whose specific outcome is the progression of the parathyroid gland over time, from its formation to the mature structure. The parathyroid gland is an organ specialised for secretion of parathyroid hormone.
|
1 | Q64729 (/IMP) |
Parathyroid gland development GO:0060017
The process whose specific outcome is the progression of the parathyroid gland over time, from its formation to the mature structure. The parathyroid gland is an organ specialised for secretion of parathyroid hormone.
|
1 | Q06900 (/ISA) |
Parathyroid gland development GO:0060017
The process whose specific outcome is the progression of the parathyroid gland over time, from its formation to the mature structure. The parathyroid gland is an organ specialised for secretion of parathyroid hormone.
|
1 | P36897 (/ISS) |
Palate development GO:0060021
The biological process whose specific outcome is the progression of the palate from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure. The palate is the partition that separates the nasal and oral cavities.
|
1 | Q06900 (/ISA) |
Pharyngeal system development GO:0060037
The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
|
1 | P36897 (/ISS) |
Retina development in camera-type eye GO:0060041
The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.
|
1 | F1LQC5 (/IEP) |
Retina development in camera-type eye GO:0060041
The process whose specific outcome is the progression of the retina over time, from its formation to the mature structure. The retina is the innermost layer or coating at the back of the eyeball, which is sensitive to light and in which the optic nerve terminates.
|
1 | P36898 (/IMP) |
Negative regulation of cardiac muscle cell proliferation GO:0060044
Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle cell proliferation.
|
1 | P38438 (/IMP) |
Positive regulation of cardiac muscle cell proliferation GO:0060045
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
|
1 | P36895 (/IMP) |
Positive regulation of cardiac muscle cell proliferation GO:0060045
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell proliferation.
|
1 | P36894 (/ISS) |
Limb development GO:0060173
The process whose specific outcome is the progression of a limb over time, from its formation to the mature structure. A limb is an appendage of an animal used for locomotion or grasping. Examples include legs, arms or some types of fin.
|
1 | O35607 (/IGI) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | Q90999 (/IEP) |
Cardiac epithelial to mesenchymal transition GO:0060317
A transition where a cardiac epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
1 | Q90999 (/TAS) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
1 | Q90999 (/ISM) |
Positive regulation of SMAD protein import into nucleus GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein import into the nucleus, i.e. the directed movement of a SMAD proteins from the cytoplasm into the nucleus. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
1 | Q06900 (/ISA) |
Atrial septum morphogenesis GO:0060413
The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another.
|
1 | O35607 (/IMP) |
Atrial septum morphogenesis GO:0060413
The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another.
|
1 | Q13873 (/ISS) |
Lung morphogenesis GO:0060425
The process in which the anatomical structures of the lung are generated and organized.
|
1 | Q62312 (/IMP) |
Bronchus development GO:0060433
The biological process whose specific outcome is the progression of a bronchus from an initial condition to its mature state. This process begins with the formation of the bronchus and ends with the mature structure. The bronchus is the portion of the airway that connects to the lungs.
|
1 | Q62312 (/IMP) |
Bronchus morphogenesis GO:0060434
The process in which the bronchus is generated and organized. The bronchus is the portion of the airway that connects to the lungs.
|
1 | Q62312 (/IMP) |
Trachea morphogenesis GO:0060439
The process in which a trachea is generated and organized. The trachea is the portion of the airway that attaches to the bronchi as it branches.
|
1 | Q62312 (/IMP) |
Trachea formation GO:0060440
The process pertaining to the initial formation of a trachea from unspecified parts. The process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the trachea is recognizable. The trachea is the portion of the airway that attaches to the bronchi as it branches.
|
1 | Q62312 (/IMP) |
Mammary gland morphogenesis GO:0060443
The process in which anatomical structures of the mammary gland are generated and organized. Morphogenesis refers to the creation of shape. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
|
1 | Q62312 (/IMP) |
Lung lobe morphogenesis GO:0060463
The process in which the anatomical structures of a lung lobe are generated and organized. A lung lobe is a projection that extends from the lung.
|
1 | Q62312 (/IMP) |
Lymphatic endothelial cell differentiation GO:0060836
The process in which a venous blood vessel endothelial cell acquires specialized features of a lymphatic vessel endothelial cell, a thin flattened cell that lines the inside surfaces of lymph vessels.
|
1 | Q61288 (/ISO) |
Neural plate pattern specification GO:0060896
The developmental process that results in the creation of defined areas or spaces within the neural plate to which cells respond and eventually are instructed to differentiate.
|
1 | P36895 (/IMP) |
Heart formation GO:0060914
The developmental process pertaining to the initial formation of the heart from unspecified parts. This process begins with the specific processes that contribute to the appearance of the heart field and the arrival of cardiac neural crest to the heart region. The process ends when the structural rudiment is recognizable.
|
1 | P36895 (/IMP) |
Cardiac muscle cell fate commitment GO:0060923
The commitment of cells to specific cardiac muscle cell fates and their capacity to differentiate into cardiac muscle cells. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
|
1 | Q04771 (/IMP) |
Cardiac muscle cell fate commitment GO:0060923
The commitment of cells to specific cardiac muscle cell fates and their capacity to differentiate into cardiac muscle cells. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
|
1 | Q90ZK6 (/ISA) |
Cardiac muscle cell fate commitment GO:0060923
The commitment of cells to specific cardiac muscle cell fates and their capacity to differentiate into cardiac muscle cells. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
|
1 | P37172 (/ISO) |
Angiogenesis involved in coronary vascular morphogenesis GO:0060978
Blood vessel formation in the heart when new vessels emerge from the proliferation of pre-existing blood vessels.
|
1 | Q64729 (/IMP) |
Coronary artery morphogenesis GO:0060982
The process in which the anatomical structures of coronary arteries are generated and organized. Coronary arteries are blood vessels that transport blood to the heart muscle.
|
1 | Q64729 (/IMP) |
Coronary artery morphogenesis GO:0060982
The process in which the anatomical structures of coronary arteries are generated and organized. Coronary arteries are blood vessels that transport blood to the heart muscle.
|
1 | P36897 (/ISS) |
Endothelial tube morphogenesis GO:0061154
The process in which the anatomical structures of a tube are generated and organized from an endothelium. Endothelium refers to the layer of cells lining blood vessels, lymphatics, the heart, and serous cavities, and is derived from bone marrow or mesoderm. Corneal endothelium is a special case, derived from neural crest cells.
|
1 | P37023 (/IMP) |
Endothelial tube morphogenesis GO:0061154
The process in which the anatomical structures of a tube are generated and organized from an endothelium. Endothelium refers to the layer of cells lining blood vessels, lymphatics, the heart, and serous cavities, and is derived from bone marrow or mesoderm. Corneal endothelium is a special case, derived from neural crest cells.
|
1 | Q61288 (/ISO) |
BMP signaling pathway involved in heart development GO:0061312
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the progression of the heart over time.
|
1 | P37172 (/IMP) |
Endocardial cushion cell fate commitment GO:0061445
The commitment of a cell to an endocardial cushion cell fate and its capacity to differentiate into an endocardial cushion cell.
|
1 | Q04771 (/IMP) |
Endocardial cushion cell fate commitment GO:0061445
The commitment of a cell to an endocardial cushion cell fate and its capacity to differentiate into an endocardial cushion cell.
|
1 | Q90ZK6 (/ISA) |
Endocardial cushion cell fate commitment GO:0061445
The commitment of a cell to an endocardial cushion cell fate and its capacity to differentiate into an endocardial cushion cell.
|
1 | P37172 (/ISO) |
Detection of hypoxia GO:0070483
The series of events in which a stimulus indicating lowered oxygen tension is received by a cell and converted into a molecular signal. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | Q90999 (/ISM) |
Cellular response to growth factor stimulus GO:0071363
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
|
1 | P36898 (/IDA) |
Cellular response to growth factor stimulus GO:0071363
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
|
1 | Q05438 (/ISS) |
Cellular response to glucocorticoid stimulus GO:0071385
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
1 | P80201 (/IEP) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
1 | Q06900 (/ISA) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
1 | Q90ZK6 (/ISA) |
Endothelial cell apoptotic process GO:0072577
Any apoptotic process in an endothelial cell. An endothelial cell comprises the outermost layer or lining of anatomical structures and can be squamous or cuboidal.
|
1 | Q13873 (/IMP) |
Endothelial cell apoptotic process GO:0072577
Any apoptotic process in an endothelial cell. An endothelial cell comprises the outermost layer or lining of anatomical structures and can be squamous or cuboidal.
|
1 | O35607 (/ISO) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
1 | P36896 (/IMP) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
1 | Q61271 (/ISO) |
Negative regulation of trophoblast cell migration GO:1901164
Any process that stops, prevents or reduces the frequency, rate or extent of trophoblast cell migration.
|
1 | Q8NER5 (/IDA) |
Negative regulation of trophoblast cell migration GO:1901164
Any process that stops, prevents or reduces the frequency, rate or extent of trophoblast cell migration.
|
1 | Q8K348 (/ISO) |
Positive regulation of trophoblast cell migration GO:1901165
Any process that activates or increases the frequency, rate or extent of trophoblast cell migration.
|
1 | P36896 (/IDA) |
Positive regulation of trophoblast cell migration GO:1901165
Any process that activates or increases the frequency, rate or extent of trophoblast cell migration.
|
1 | Q61271 (/ISO) |
Negative regulation of chorionic trophoblast cell proliferation GO:1901383
Any process that stops, prevents or reduces the frequency, rate or extent of chorionic trophoblast cell proliferation.
|
1 | Q8NER5 (/IMP) |
Negative regulation of chorionic trophoblast cell proliferation GO:1901383
Any process that stops, prevents or reduces the frequency, rate or extent of chorionic trophoblast cell proliferation.
|
1 | Q8K348 (/ISO) |
Positive regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902043
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
|
1 | P36898 (/IGI) |
Negative regulation of chondrocyte proliferation GO:1902731
Any process that stops, prevents, or reduces the frequency, rate or extent of the multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage.
|
1 | O35607 (/ISO) |
Negative regulation of pri-miRNA transcription from RNA polymerase II promoter GO:1902894
Any process that stops, prevents or reduces the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter.
|
1 | P80204 (/IMP) |
Positive regulation of pri-miRNA transcription from RNA polymerase II promoter GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter.
|
1 | P36895 (/IDA) |
Positive regulation of pri-miRNA transcription from RNA polymerase II promoter GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription from RNA polymerase II promoter.
|
1 | P80204 (/IMP) |
Regulation of eating behavior GO:1903998
Any process that modulates the frequency, rate or extent of eating behavior.
|
1 | P20792 (/IGI) |
Positive regulation of cardiac ventricle development GO:1904414
Any process that activates or increases the frequency, rate or extent of cardiac ventricle development.
|
1 | P36895 (/IMP) |
Positive regulation of cardiac ventricle development GO:1904414
Any process that activates or increases the frequency, rate or extent of cardiac ventricle development.
|
1 | P36894 (/ISS) |
Positive regulation of vascular smooth muscle cell proliferation GO:1904707
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation.
|
1 | P36895 (/ISO) |
Positive regulation of occluding junction disassembly GO:1905075
Any process that activates or increases the frequency, rate or extent of occluding junction disassembly.
|
1 | Q64729 (/IGI) |
Epicardium morphogenesis GO:1905223
The developmental process by which an epicardium is generated and organized.
|
1 | Q64729 (/IMP) |
Fibrous ring of heart morphogenesis GO:1905285
The developmental process by which a fibrous ring of heart is generated and organized.
|
1 | P36895 (/IMP) |
Fibrous ring of heart morphogenesis GO:1905285
The developmental process by which a fibrous ring of heart is generated and organized.
|
1 | P36894 (/ISS) |
Semi-lunar valve development GO:1905314
The process whose specific outcome is the progression of a semi-lunar valve over time, from its formation to the mature structure.
|
1 | O35607 (/IMP) |
Semi-lunar valve development GO:1905314
The process whose specific outcome is the progression of a semi-lunar valve over time, from its formation to the mature structure.
|
1 | Q13873 (/ISS) |
Lens fiber cell apoptotic process GO:1990086
Any apoptotic process in a lens fiber cell. Lens fiber cells are elongated, tightly packed cells that make up the bulk of the mature lens in a camera-type eye.
|
1 | Q62312 (/IDA) |
Positive regulation of determination of dorsal identity GO:2000017
Any process that activates or increases the frequency, rate or extent of determination of dorsal identity.
|
1 | Q04771 (/IDA) |
Positive regulation of determination of dorsal identity GO:2000017
Any process that activates or increases the frequency, rate or extent of determination of dorsal identity.
|
1 | Q90ZK6 (/ISA) |
Positive regulation of determination of dorsal identity GO:2000017
Any process that activates or increases the frequency, rate or extent of determination of dorsal identity.
|
1 | P37172 (/ISO) |
Negative regulation of DNA biosynthetic process GO:2000279
Any process that stops, prevents or reduces the frequency, rate or extent of DNA biosynthetic process.
|
1 | O42124 (/ISS) |
Positive regulation of reactive oxygen species metabolic process GO:2000379
Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.
|
1 | P37173 (/IMP) |
Positive regulation of reactive oxygen species metabolic process GO:2000379
Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.
|
1 | Q90999 (/ISA) |
Positive regulation of reactive oxygen species metabolic process GO:2000379
Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.
|
1 | Q62312 (/ISO) |
Positive regulation of CD4-positive, alpha-beta T cell proliferation GO:2000563
Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation.
|
1 | P37173 (/IDA) |
Positive regulation of CD4-positive, alpha-beta T cell proliferation GO:2000563
Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell proliferation.
|
1 | Q62312 (/ISO) |
Regulation of cellular senescence GO:2000772
Any process that modulates the frequency, rate or extent of cellular senescence.
|
1 | P36895 (/IGI) |
Positive regulation of apoptotic signaling pathway GO:2001235
Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway.
|
1 | P36897 (/IDA) |
Positive regulation of apoptotic signaling pathway GO:2001235
Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway.
|
1 | Q06900 (/ISA) |
Positive regulation of apoptotic signaling pathway GO:2001235
Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway.
|
1 | Q64729 (/ISO) |
There are 92 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
75 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
A0A087RK12 (/ISS)
A0A087VDQ2 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
(65 more) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
75 |
A0A060YBJ3 (/ISS)
A0A087QH05 (/ISS)
A0A087RK12 (/ISS)
A0A087VDQ2 (/ISS)
B4DY26 (/ISS)
D2H0G0 (/ISS)
E9Q418 (/ISS)
F1PS63 (/ISS)
F6VGC3 (/ISS)
F6X0S8 (/ISS)
(65 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
30 |
A0A0B4K7J3 (/ISS)
A0A0B4KG59 (/ISS)
M9PE88 (/ISS)
O00238 (/ISS)
O46680 (/ISS)
P20792 (/ISS)
P80203 (/ISS)
Q05438 (/ISS)
Q24229 (/ISS)
Q24326 (/ISS)
(20 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
18 |
B4DY26 (/IDA)
O35607 (/IDA)
P36894 (/IDA)
P36897 (/IDA)
P36898 (/IDA)
P37023 (/IDA)
P37173 (/IDA)
P50488 (/IDA)
P70539 (/IDA)
Q13873 (/IDA)
(8 more) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
14 |
O00238 (/TAS)
P27037 (/TAS)
P27038 (/TAS)
P27040 (/TAS)
P36894 (/TAS)
P36896 (/TAS)
P36897 (/TAS)
P37023 (/TAS)
P37173 (/TAS)
Q13705 (/TAS)
(4 more) |
Early endosome GO:0005769
A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
|
10 | M9PE88 (/IDA) Q24326 (/IDA) Q7JQ37 (/IDA) Q7KTP1 (/IDA) Q8IPK9 (/IDA) Q95SI0 (/IDA) Q95V83 (/IDA) Q9NGX8 (/IDA) Q9VMT1 (/IDA) Q9VZI9 (/IDA) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
9 | A0A0B4K7J3 (/ISS) O73736 (/ISS) Q28041 (/ISS) Q7JPM7 (/ISS) Q7JPN8 (/ISS) Q7JQ36 (/ISS) Q7JQ39 (/ISS) Q95U21 (/ISS) Q9DGI6 (/ISS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
8 | F1LQC5 (/IDA) O73736 (/IDA) P27037 (/IDA) P38438 (/IDA) P70539 (/IDA) Q13705 (/IDA) Q90669 (/IDA) Q9DGI6 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
8 | P36896 (/IDA) P38438 (/IDA) Q24326 (/IDA) Q7JQ37 (/IDA) Q7KTP1 (/IDA) Q8IPK9 (/IDA) Q95SI0 (/IDA) Q9VMT1 (/IDA) |
Activin receptor complex GO:0048179
A protein complex that acts as an activin receptor. Heterodimeric activin receptors, comprising one Type I activin receptor and one Type II receptor polypeptide, and heterotrimeric receptors have been observed.
|
8 | A0A0B4KG59 (/IPI) A1Z7L8 (/IPI) A1Z7L9 (/IPI) Q23975 (/IPI) Q24229 (/IPI) Q24468 (/IPI) Q7YU60 (/IPI) Q95T01 (/IPI) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
7 | O35607 (/IDA) P27038 (/IDA) P36896 (/IDA) P36897 (/IDA) P37023 (/IDA) P38438 (/IDA) P70539 (/IDA) |
Multivesicular body GO:0005771
A type of endosome in which regions of the limiting endosomal membrane invaginate to form internal vesicles; membrane proteins that enter the internal vesicles are sequestered from the cytoplasm.
|
6 | Q24326 (/IDA) Q7JQ37 (/IDA) Q7KTP1 (/IDA) Q8IPK9 (/IDA) Q95SI0 (/IDA) Q9VMT1 (/IDA) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
6 | P36896 (/IDA) P37023 (/IDA) P37172 (/IDA) P38438 (/IDA) Q04771 (/IDA) Q13873 (/IDA) |
Activin receptor complex GO:0048179
A protein complex that acts as an activin receptor. Heterodimeric activin receptors, comprising one Type I activin receptor and one Type II receptor polypeptide, and heterotrimeric receptors have been observed.
|
6 | A1Z7L8 (/ISS) A1Z7L9 (/ISS) Q23975 (/ISS) Q28041 (/ISS) Q7YU60 (/ISS) Q8K348 (/ISS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
5 | O35607 (/ISO) P36895 (/ISO) Q61288 (/ISO) Q62312 (/ISO) Q64729 (/ISO) |
Dendrite GO:0030425
A neuron projection that has a short, tapering, often branched, morphology, receives and integrates signals from other neurons or from sensory stimuli, and conducts a nerve impulse towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body.
|
5 | F1LQC5 (/IDA) M0R3J4 (/IDA) P80203 (/IDA) Q569A5 (/IDA) Q78EA7 (/IDA) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
5 | F1LQC5 (/IDA) M0R3J4 (/IDA) P80203 (/IDA) Q569A5 (/IDA) Q78EA7 (/IDA) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
5 | P27038 (/ISO) P27040 (/ISO) Q61271 (/ISO) Q62312 (/ISO) Q64729 (/ISO) |
Spanning component of plasma membrane GO:0044214
The component of the plasma membrane consisting of gene products and protein complexes that have some part that spans both leaflets of the membrane.
|
5 | F1NTD3 (/TAS) F1P3H0 (/TAS) Q05438 (/TAS) Q13873 (/TAS) Q90754 (/TAS) |
Activin receptor complex GO:0048179
A protein complex that acts as an activin receptor. Heterodimeric activin receptors, comprising one Type I activin receptor and one Type II receptor polypeptide, and heterotrimeric receptors have been observed.
|
5 | P36896 (/IDA) P70539 (/IDA) P80201 (/IDA) Q04771 (/IDA) Q8NER5 (/IDA) |
BMP receptor complex GO:0070724
A protein complex that acts as a receptor for bone morphogenetic proteins (BMPs); a homo- or heterodimer of type I and/or type II BMP receptor subunits.
|
5 | B3DJG0 (/IDA) O73736 (/IDA) O93243 (/IDA) Q1RLX1 (/IDA) Q9DGI6 (/IDA) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
4 | A0A0B4KG59 (/ISM) Q24229 (/ISM) Q24468 (/ISM) Q95T01 (/ISM) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
4 | O35607 (/ISO) P37172 (/ISO) Q61271 (/ISO) Q61288 (/ISO) |
Caveola GO:0005901
A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.
|
4 | F1LQC5 (/IDA) P37173 (/IDA) P38438 (/IDA) P80204 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
4 | Q61271 (/ISO) Q61288 (/ISO) Q64729 (/ISO) Q8K348 (/ISO) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
4 | O46680 (/ISS) P80204 (/ISS) Q5CD18 (/ISS) Q64729 (/ISS) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
4 | P36897 (/IDA) P37173 (/IDA) P38438 (/IDA) P80204 (/IDA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
4 | O46680 (/ISS) Q5CD18 (/ISS) Q62312 (/ISS) Q64729 (/ISS) |
Synapse GO:0045202
The junction between a nerve fiber of one neuron and another neuron, muscle fiber or glial cell. As the nerve fiber approaches the synapse it enlarges into a specialized structure, the presynaptic nerve ending, which contains mitochondria and synaptic vesicles. At the tip of the nerve ending is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic nerve ending secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane.
|
4 | M9PE88 (/IDA) Q95V83 (/IDA) Q9NGX8 (/IDA) Q9VZI9 (/IDA) |
Recycling endosome GO:0055037
An organelle consisting of a network of tubules that functions in targeting molecules, such as receptors transporters and lipids, to the plasma membrane.
|
4 | M9PE88 (/IDA) Q95V83 (/IDA) Q9NGX8 (/IDA) Q9VZI9 (/IDA) |
Transforming growth factor beta receptor complex GO:0070022
A homodimeric receptor complex that consists of two TGF-beta receptor monomers.
|
4 | P36897 (/IC) P37173 (/IC) P38438 (/IC) P80204 (/IC) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
3 | P27037 (/TAS) Q13705 (/TAS) Q61271 (/TAS) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
3 | P36894 (/IDA) P37173 (/IDA) Q62312 (/IDA) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
3 | Q06900 (/IDA) Q90669 (/IDA) Q90999 (/IDA) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
3 | B4DY26 (/IDA) P36897 (/IDA) Q5T7S2 (/IDA) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
3 | P36896 (/IDA) P36897 (/IDA) P37173 (/IDA) |
Activin receptor complex GO:0048179
A protein complex that acts as an activin receptor. Heterodimeric activin receptors, comprising one Type I activin receptor and one Type II receptor polypeptide, and heterotrimeric receptors have been observed.
|
3 | P37172 (/ISO) Q61271 (/ISO) Q8K348 (/ISO) |
Cell GO:0005623
The basic structural and functional unit of all organisms. Includes the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope.
|
2 | Q06900 (/IDA) Q90999 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | P27038 (/ISO) P27040 (/ISO) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | Q06900 (/ISA) Q90999 (/ISA) |
Caveola GO:0005901
A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.
|
2 | Q62312 (/ISO) Q64729 (/ISO) |
Cell cortex GO:0005938
The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins.
|
2 | O73736 (/IDA) Q9DGI6 (/IDA) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
2 | P36895 (/ISO) Q62312 (/ISO) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
2 | Q06900 (/IC) Q90ZK6 (/IC) |
Apical plasma membrane GO:0016324
The region of the plasma membrane located at the apical end of the cell.
|
2 | F1LQC5 (/IDA) P80204 (/IDA) |
Protein complex GO:0043234
A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.
|
2 | P80204 (/IDA) Q13705 (/IDA) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | P27037 (/IPI) Q13705 (/IPI) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | Q06900 (/ISA) Q90999 (/ISA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
2 | Q06900 (/ISA) Q90999 (/ISA) |
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
|
2 | Q62312 (/ISO) Q64729 (/ISO) |
Basal part of cell GO:0045178
The region of a cell situated near the base. For example, in a polarized epithelial cell, the basal surface rests on the basal lamina that separates the epithelium from other tissue.
|
2 | F1NCI7 (/IDA) Q90670 (/IDA) |
HFE-transferrin receptor complex GO:1990712
A protein complex containing at least HFE and a transferrin receptor (either TFR1/TFRC or TFR2), proposed to play a role in the sensing of transferrin-bound Fe (Fe2-Tf) on the plasma membrane to regulate hepcidin transcription.
|
2 | O00238 (/IC) P36894 (/IC) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | Q13873 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
1 | O35607 (/ISO) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
1 | Q13873 (/IDA) |
Nucleoplasm GO:0005654
That part of the nuclear content other than the chromosomes or the nucleolus.
|
1 | O35607 (/ISO) |
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
|
1 | Q64729 (/IDA) |
Endosome GO:0005768
A vacuole to which materials ingested by endocytosis are delivered.
|
1 | Q06900 (/ISA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | Q61271 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
1 | P37173 (/TAS) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | O00238 (/IC) |
Integral component of plasma membrane GO:0005887
The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | Q90ZK6 (/ISA) |
Caveola GO:0005901
A membrane raft that forms small pit, depression, or invagination that communicates with the outside of a cell and extends inward, indenting the cytoplasm and the cell membrane. Examples include flask-shaped invaginations of the plasma membrane in adipocytes associated with caveolin proteins, and minute pits or incuppings of the cell membrane formed during pinocytosis. Caveolae may be pinched off to form free vesicles within the cytoplasm.
|
1 | Q90999 (/ISA) |
Cell-cell adherens junction GO:0005913
An adherens junction which connects a cell to another cell.
|
1 | Q13873 (/IDA) |
Cell-cell adherens junction GO:0005913
An adherens junction which connects a cell to another cell.
|
1 | O35607 (/ISO) |
Bicellular tight junction GO:0005923
An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.
|
1 | P36897 (/IDA) |
Bicellular tight junction GO:0005923
An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.
|
1 | Q06900 (/ISA) |
Bicellular tight junction GO:0005923
An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.
|
1 | Q64729 (/ISO) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
1 | Q90999 (/ISA) |
External side of plasma membrane GO:0009897
The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
|
1 | Q90999 (/TAS) |
Basal plasma membrane GO:0009925
The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
|
1 | F1LQC5 (/IDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
1 | Q06900 (/ISA) |
Postsynaptic density GO:0014069
An electron dense network of proteins within and adjacent to the postsynaptic membrane in asymetric synapses. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components.
|
1 | O35607 (/IDA) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | P37173 (/IDA) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | Q90999 (/ISA) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | Q62312 (/ISO) |
Integral component of membrane GO:0016021
The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
|
1 | P36894 (/TAS) |
Basolateral plasma membrane GO:0016323
The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
|
1 | P80204 (/IDA) |
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support for cells or tissues.
|
1 | Q90999 (/ISM) |
Inhibin-betaglycan-ActRII complex GO:0034673
A protein complex that consists of inhibin, type III transforming growth factor beta receptor (also known as betaglycan), and the type II activin receptor ActRII. The complex is thought to negatively regulate the activity of activin B.
|
1 | P27037 (/IDA) |
Inhibin-betaglycan-ActRII complex GO:0034673
A protein complex that consists of inhibin, type III transforming growth factor beta receptor (also known as betaglycan), and the type II activin receptor ActRII. The complex is thought to negatively regulate the activity of activin B.
|
1 | P27038 (/ISO) |
Intracellular membrane-bounded organelle GO:0043231
Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
|
1 | Q64729 (/ISO) |
Protein complex GO:0043234
A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical.
|
1 | P27040 (/ISO) |
Receptor complex GO:0043235
Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
1 | O00238 (/TAS) |
Apical part of cell GO:0045177
The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.
|
1 | P37172 (/IDA) |
Apical part of cell GO:0045177
The region of a polarized cell that forms a tip or is distal to a base. For example, in a polarized epithelial cell, the apical region has an exposed surface and lies opposite to the basal lamina that separates the epithelium from other tissue.
|
1 | Q90ZK6 (/ISA) |
Activin receptor complex GO:0048179
A protein complex that acts as an activin receptor. Heterodimeric activin receptors, comprising one Type I activin receptor and one Type II receptor polypeptide, and heterotrimeric receptors have been observed.
|
1 | Q90ZK6 (/ISA) |
Activin receptor complex GO:0048179
A protein complex that acts as an activin receptor. Heterodimeric activin receptors, comprising one Type I activin receptor and one Type II receptor polypeptide, and heterotrimeric receptors have been observed.
|
1 | P38444 (/TAS) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
1 | P36896 (/IDA) |
Extracellular exosome GO:0070062
A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
|
1 | Q61271 (/ISO) |
Presynapse GO:0098793
The part of a synapse that is part of the presynaptic cell.
|
1 | Q9VMT1 (/IDA) |
Trans-synaptic protein complex GO:0098820
A protein complex that spans the synaptic cleft and has parts in both the pre- and post-synaptic membranes.
|
1 | M9PE88 (/IGI) |